Project
avrg: GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for SP4_PML
Z-value: 5.67
Motif logo
Transcription factors associated with SP4_PML
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
SP4
|
ENSG00000105866.15 | SP4 |
|
PML
|
ENSG00000140464.20 | PML |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| SP4 | hg38_v1_chr7_+_21428184_21428227, hg38_v1_chr7_+_21428023_21428112 | 0.21 | 1.4e-03 | Click! |
| PML | hg38_v1_chr15_+_73994777_73994803 | -0.11 | 1.0e-01 | Click! |
Activity profile of SP4_PML motif
Sorted Z-values of SP4_PML motif
Network of associatons between targets according to the STRING database.
First level regulatory network of SP4_PML
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 20.6 | 82.4 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
| 20.6 | 102.8 | GO:1902612 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 18.7 | 112.3 | GO:0060313 | negative regulation of blood vessel remodeling(GO:0060313) |
| 16.8 | 67.0 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
| 16.3 | 48.8 | GO:0070650 | endoplasmic reticulum polarization(GO:0061163) actin filament bundle retrograde transport(GO:0061573) actin filament bundle distribution(GO:0070650) |
| 15.5 | 46.6 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
| 14.8 | 44.5 | GO:0060988 | lipid tube assembly(GO:0060988) |
| 13.7 | 41.2 | GO:0036146 | cellular response to mycotoxin(GO:0036146) |
| 13.2 | 39.5 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 13.2 | 65.8 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 12.9 | 38.8 | GO:0098582 | innate vocalization behavior(GO:0098582) |
| 12.9 | 77.2 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
| 12.5 | 50.1 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
| 11.9 | 35.7 | GO:0051939 | gamma-aminobutyric acid import(GO:0051939) |
| 11.8 | 58.9 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 11.7 | 58.5 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
| 11.5 | 103.9 | GO:0003190 | atrioventricular valve formation(GO:0003190) |
| 11.2 | 67.3 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
| 11.0 | 22.1 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
| 10.9 | 32.7 | GO:0021722 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 10.4 | 41.4 | GO:1904980 | positive regulation of endosome organization(GO:1904980) |
| 10.1 | 30.2 | GO:0097476 | spinal cord motor neuron migration(GO:0097476) lateral motor column neuron migration(GO:0097477) |
| 9.9 | 59.7 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 9.9 | 128.6 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 9.7 | 38.8 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
| 9.6 | 57.4 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
| 9.2 | 36.9 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 9.0 | 45.0 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 8.6 | 34.5 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 8.3 | 75.0 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
| 7.9 | 39.6 | GO:2001074 | regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
| 7.7 | 38.3 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 7.6 | 68.4 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
| 7.5 | 22.5 | GO:2000374 | regulation of oxygen metabolic process(GO:2000374) |
| 7.3 | 21.8 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 7.1 | 35.4 | GO:0061107 | seminal vesicle development(GO:0061107) |
| 7.0 | 35.1 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 6.7 | 20.1 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 6.6 | 26.5 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
| 6.6 | 26.4 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
| 6.5 | 130.7 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
| 6.5 | 32.5 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
| 6.3 | 12.6 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 6.3 | 6.3 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
| 6.2 | 25.0 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 6.2 | 18.7 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 6.2 | 55.6 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 6.0 | 18.1 | GO:0071206 | establishment of protein localization to juxtaparanode region of axon(GO:0071206) |
| 6.0 | 18.1 | GO:0019075 | virus maturation(GO:0019075) |
| 6.0 | 18.0 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
| 6.0 | 18.0 | GO:1903892 | negative regulation of ATF6-mediated unfolded protein response(GO:1903892) |
| 6.0 | 17.9 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
| 5.8 | 11.7 | GO:1900275 | negative regulation of phospholipase C activity(GO:1900275) |
| 5.8 | 17.4 | GO:0042938 | dipeptide transport(GO:0042938) |
| 5.8 | 28.8 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
| 5.7 | 5.7 | GO:0072301 | regulation of metanephric glomerular mesangial cell proliferation(GO:0072301) |
| 5.6 | 16.9 | GO:0090176 | microtubule cytoskeleton organization involved in establishment of planar polarity(GO:0090176) |
| 5.5 | 11.0 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
| 5.5 | 49.6 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
| 5.4 | 16.2 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
| 5.4 | 21.5 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
| 5.4 | 16.1 | GO:0009183 | purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
| 5.4 | 48.3 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 5.4 | 48.3 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 5.3 | 16.0 | GO:1901899 | positive regulation of relaxation of cardiac muscle(GO:1901899) |
| 5.3 | 69.1 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
| 5.3 | 10.6 | GO:1903233 | regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) |
| 5.3 | 84.4 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 5.3 | 21.1 | GO:0071110 | protein biotinylation(GO:0009305) histone biotinylation(GO:0071110) |
| 5.2 | 15.7 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 5.2 | 10.5 | GO:1905053 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 5.2 | 36.6 | GO:1905123 | regulation of glucosylceramidase activity(GO:1905123) |
| 5.2 | 20.8 | GO:2001247 | positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
| 5.2 | 10.4 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 5.1 | 10.3 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
| 5.1 | 35.8 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 5.0 | 40.2 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
| 5.0 | 39.9 | GO:0061709 | reticulophagy(GO:0061709) |
| 5.0 | 49.8 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 4.9 | 19.8 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 4.9 | 9.9 | GO:0090034 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 4.9 | 14.8 | GO:0071139 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 4.9 | 14.6 | GO:0098928 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
| 4.9 | 14.6 | GO:1904017 | cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 4.9 | 4.9 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 4.8 | 19.4 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
| 4.8 | 33.9 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
| 4.8 | 14.5 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
| 4.8 | 14.4 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 4.8 | 33.5 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 4.7 | 42.4 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 4.7 | 88.7 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
| 4.6 | 64.0 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 4.5 | 50.0 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 4.5 | 27.1 | GO:0035604 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) |
| 4.5 | 54.1 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
| 4.5 | 54.0 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 4.5 | 13.5 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 4.5 | 35.9 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 4.5 | 22.4 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
| 4.5 | 4.5 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 4.5 | 8.9 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
| 4.5 | 8.9 | GO:0006850 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 4.5 | 13.4 | GO:0008355 | olfactory learning(GO:0008355) |
| 4.5 | 44.5 | GO:0090292 | nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 4.4 | 44.4 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 4.4 | 88.4 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 4.4 | 123.7 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 4.4 | 48.3 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
| 4.4 | 13.1 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
| 4.3 | 17.2 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 4.3 | 68.4 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
| 4.2 | 17.0 | GO:0071418 | cellular response to amine stimulus(GO:0071418) |
| 4.2 | 50.9 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 4.2 | 16.9 | GO:0051866 | general adaptation syndrome(GO:0051866) |
| 4.2 | 12.6 | GO:0036047 | protein demalonylation(GO:0036046) peptidyl-lysine demalonylation(GO:0036047) protein desuccinylation(GO:0036048) peptidyl-lysine desuccinylation(GO:0036049) protein deglutarylation(GO:0061698) peptidyl-lysine deglutarylation(GO:0061699) |
| 4.2 | 4.2 | GO:0060155 | platelet dense granule organization(GO:0060155) |
| 4.2 | 58.4 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 4.1 | 12.3 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
| 4.1 | 8.2 | GO:0035973 | aggrephagy(GO:0035973) |
| 4.1 | 32.6 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 4.0 | 8.1 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
| 4.0 | 24.3 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
| 4.0 | 4.0 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
| 4.0 | 20.0 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
| 4.0 | 16.0 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
| 4.0 | 4.0 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
| 3.9 | 23.5 | GO:0010748 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
| 3.9 | 3.9 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
| 3.9 | 19.3 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 3.8 | 19.0 | GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 3.8 | 15.1 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
| 3.8 | 78.8 | GO:0051645 | Golgi localization(GO:0051645) |
| 3.8 | 15.0 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
| 3.7 | 26.2 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
| 3.7 | 3.7 | GO:0051935 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) |
| 3.7 | 14.9 | GO:0001519 | peptide amidation(GO:0001519) protein amidation(GO:0018032) peptide modification(GO:0031179) |
| 3.7 | 37.2 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 3.7 | 3.7 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
| 3.7 | 7.4 | GO:0007412 | axon target recognition(GO:0007412) |
| 3.7 | 11.0 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
| 3.7 | 36.6 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 3.6 | 10.9 | GO:0070314 | G1 to G0 transition(GO:0070314) |
| 3.6 | 3.6 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
| 3.6 | 7.2 | GO:1901628 | positive regulation of postsynaptic membrane organization(GO:1901628) |
| 3.6 | 10.8 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 3.6 | 57.6 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 3.6 | 10.8 | GO:0071321 | cellular response to cGMP(GO:0071321) |
| 3.6 | 57.3 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
| 3.5 | 38.7 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
| 3.5 | 87.8 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 3.5 | 17.5 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
| 3.5 | 13.9 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 3.4 | 6.9 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
| 3.4 | 3.4 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
| 3.4 | 6.8 | GO:0070662 | mast cell proliferation(GO:0070662) |
| 3.4 | 17.1 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 3.4 | 13.6 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 3.4 | 23.7 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 3.4 | 10.1 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
| 3.4 | 3.4 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
| 3.3 | 10.0 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
| 3.3 | 16.7 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 3.3 | 13.3 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
| 3.3 | 9.9 | GO:1905247 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 3.3 | 23.1 | GO:1902075 | cellular response to salt(GO:1902075) |
| 3.3 | 9.9 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
| 3.3 | 29.6 | GO:0002278 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
| 3.3 | 65.6 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 3.3 | 26.2 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 3.3 | 22.8 | GO:0010044 | response to aluminum ion(GO:0010044) |
| 3.3 | 9.8 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
| 3.2 | 6.5 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 3.2 | 6.5 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 3.2 | 6.4 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 3.2 | 16.0 | GO:0097338 | response to clozapine(GO:0097338) |
| 3.2 | 25.5 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 3.2 | 38.0 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 3.2 | 9.5 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
| 3.1 | 6.3 | GO:0060086 | circadian temperature homeostasis(GO:0060086) |
| 3.1 | 47.1 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 3.1 | 12.5 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
| 3.1 | 9.3 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 3.1 | 15.4 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
| 3.1 | 27.7 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
| 3.1 | 9.2 | GO:1902905 | positive regulation of fibril organization(GO:1902905) |
| 3.0 | 51.5 | GO:0008089 | anterograde axonal transport(GO:0008089) |
| 3.0 | 24.2 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 3.0 | 15.1 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 3.0 | 18.1 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
| 3.0 | 9.0 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
| 3.0 | 3.0 | GO:1904397 | negative regulation of neuromuscular junction development(GO:1904397) |
| 3.0 | 14.8 | GO:0030070 | insulin processing(GO:0030070) |
| 2.9 | 26.5 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
| 2.9 | 5.9 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
| 2.9 | 2.9 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
| 2.9 | 8.8 | GO:1902462 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 2.9 | 11.7 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
| 2.9 | 145.4 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
| 2.9 | 11.6 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 2.9 | 138.5 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 2.9 | 17.3 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 2.9 | 2.9 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) |
| 2.9 | 11.4 | GO:0072660 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 2.9 | 39.9 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 2.8 | 2.8 | GO:0090212 | negative regulation of establishment of blood-brain barrier(GO:0090212) |
| 2.8 | 30.9 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
| 2.8 | 59.0 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
| 2.8 | 126.3 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
| 2.8 | 33.6 | GO:0046958 | nonassociative learning(GO:0046958) |
| 2.8 | 16.8 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 2.8 | 114.2 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 2.8 | 19.4 | GO:0033029 | regulation of neutrophil apoptotic process(GO:0033029) |
| 2.7 | 13.7 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
| 2.7 | 24.6 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 2.7 | 8.2 | GO:0031455 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 2.7 | 13.6 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 2.7 | 10.8 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
| 2.7 | 5.4 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 2.7 | 8.1 | GO:0018395 | peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine(GO:0018395) histone arginine demethylation(GO:0070077) histone H3-R2 demethylation(GO:0070078) histone H4-R3 demethylation(GO:0070079) |
| 2.7 | 83.6 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) |
| 2.7 | 5.4 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 2.7 | 13.3 | GO:0021626 | hindbrain maturation(GO:0021578) cerebellum maturation(GO:0021590) central nervous system maturation(GO:0021626) cerebellar cortex maturation(GO:0021699) |
| 2.7 | 5.3 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) positive regulation of synaptic vesicle endocytosis(GO:1900244) positive regulation of synaptic vesicle transport(GO:1902805) positive regulation of synaptic vesicle recycling(GO:1903423) |
| 2.6 | 18.5 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 2.6 | 10.6 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
| 2.6 | 7.9 | GO:1990519 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 2.6 | 15.8 | GO:1990034 | calcium ion export from cell(GO:1990034) |
| 2.6 | 13.1 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
| 2.6 | 7.9 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
| 2.6 | 26.2 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
| 2.6 | 23.4 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 2.6 | 20.8 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
| 2.6 | 10.4 | GO:0035696 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
| 2.6 | 5.2 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
| 2.6 | 12.8 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 2.6 | 12.8 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
| 2.5 | 7.6 | GO:0098935 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 2.5 | 2.5 | GO:1903758 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 2.5 | 7.6 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
| 2.5 | 10.2 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
| 2.5 | 5.1 | GO:0043587 | tongue morphogenesis(GO:0043587) |
| 2.5 | 15.2 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 2.5 | 2.5 | GO:1901859 | negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
| 2.5 | 7.6 | GO:1990164 | histone H2A phosphorylation(GO:1990164) |
| 2.5 | 20.2 | GO:2000580 | regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 2.5 | 7.6 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
| 2.5 | 5.0 | GO:0046730 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 2.5 | 10.1 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
| 2.5 | 12.6 | GO:0010816 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 2.5 | 10.1 | GO:0097104 | postsynaptic membrane assembly(GO:0097104) |
| 2.5 | 40.2 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
| 2.5 | 20.0 | GO:0016322 | neuron remodeling(GO:0016322) |
| 2.5 | 10.0 | GO:0030472 | mitotic spindle organization in nucleus(GO:0030472) |
| 2.5 | 7.5 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
| 2.5 | 5.0 | GO:1902722 | positive regulation of prolactin secretion(GO:1902722) |
| 2.5 | 42.4 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
| 2.5 | 5.0 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
| 2.5 | 9.9 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 2.5 | 12.3 | GO:1902998 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 2.5 | 19.7 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
| 2.5 | 66.4 | GO:0045187 | regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
| 2.5 | 9.8 | GO:2000638 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
| 2.4 | 7.3 | GO:1904692 | positive regulation of type B pancreatic cell proliferation(GO:1904692) |
| 2.4 | 7.3 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
| 2.4 | 28.9 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
| 2.4 | 14.4 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
| 2.4 | 4.8 | GO:0032242 | regulation of nucleoside transport(GO:0032242) |
| 2.4 | 35.8 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 2.4 | 9.5 | GO:0035627 | ceramide transport(GO:0035627) |
| 2.4 | 7.1 | GO:0010935 | macrophage cytokine production(GO:0010934) regulation of macrophage cytokine production(GO:0010935) negative regulation of macrophage cytokine production(GO:0010936) |
| 2.4 | 9.5 | GO:1904141 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) positive regulation of microglial cell migration(GO:1904141) |
| 2.4 | 7.1 | GO:0001927 | exocyst assembly(GO:0001927) |
| 2.3 | 7.0 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
| 2.3 | 20.9 | GO:0008343 | adult feeding behavior(GO:0008343) |
| 2.3 | 25.5 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
| 2.3 | 6.9 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
| 2.3 | 9.2 | GO:0002357 | defense response to tumor cell(GO:0002357) |
| 2.3 | 2.3 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
| 2.3 | 4.6 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
| 2.3 | 9.1 | GO:1990834 | response to odorant(GO:1990834) |
| 2.3 | 6.8 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 2.3 | 9.1 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
| 2.3 | 18.1 | GO:0035524 | proline transmembrane transport(GO:0035524) |
| 2.3 | 4.5 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
| 2.3 | 24.8 | GO:0009414 | response to water deprivation(GO:0009414) |
| 2.2 | 9.0 | GO:0042713 | sperm ejaculation(GO:0042713) |
| 2.2 | 6.7 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 2.2 | 11.2 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 2.2 | 29.0 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
| 2.2 | 2.2 | GO:1902256 | apoptotic process involved in outflow tract morphogenesis(GO:0003275) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) |
| 2.2 | 2.2 | GO:1903802 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
| 2.2 | 4.5 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 2.2 | 13.4 | GO:1901731 | positive regulation of platelet aggregation(GO:1901731) |
| 2.2 | 6.7 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
| 2.2 | 13.2 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
| 2.2 | 11.0 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
| 2.2 | 13.2 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
| 2.2 | 6.5 | GO:0014060 | regulation of epinephrine secretion(GO:0014060) negative regulation of epinephrine secretion(GO:0032811) epinephrine secretion(GO:0048242) |
| 2.2 | 4.3 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 2.1 | 150.4 | GO:0035773 | insulin secretion involved in cellular response to glucose stimulus(GO:0035773) |
| 2.1 | 10.7 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 2.1 | 4.3 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
| 2.1 | 6.3 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
| 2.1 | 27.4 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
| 2.1 | 2.1 | GO:0010692 | regulation of alkaline phosphatase activity(GO:0010692) |
| 2.1 | 12.6 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
| 2.1 | 8.4 | GO:0032456 | endocytic recycling(GO:0032456) |
| 2.1 | 12.6 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 2.1 | 4.2 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
| 2.1 | 2.1 | GO:0032252 | secretory granule localization(GO:0032252) |
| 2.1 | 2.1 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
| 2.1 | 14.5 | GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
| 2.1 | 63.8 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
| 2.0 | 8.2 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
| 2.0 | 6.1 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 2.0 | 14.2 | GO:0072592 | oxygen metabolic process(GO:0072592) |
| 2.0 | 10.1 | GO:0048570 | notochord morphogenesis(GO:0048570) |
| 2.0 | 2.0 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 2.0 | 12.1 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 2.0 | 93.6 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
| 2.0 | 6.0 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 2.0 | 47.5 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
| 2.0 | 3.9 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
| 2.0 | 7.8 | GO:0021886 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
| 2.0 | 5.9 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
| 2.0 | 31.3 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
| 1.9 | 3.9 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
| 1.9 | 7.8 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
| 1.9 | 5.8 | GO:0060437 | lung growth(GO:0060437) |
| 1.9 | 11.6 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
| 1.9 | 9.6 | GO:0034214 | protein hexamerization(GO:0034214) |
| 1.9 | 19.2 | GO:0031643 | positive regulation of myelination(GO:0031643) |
| 1.9 | 3.8 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
| 1.9 | 11.5 | GO:0051414 | response to cortisol(GO:0051414) |
| 1.9 | 3.8 | GO:0070459 | prolactin secretion(GO:0070459) |
| 1.9 | 7.6 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 1.9 | 11.4 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
| 1.9 | 5.7 | GO:0055099 | detection of hormone stimulus(GO:0009720) detection of endogenous stimulus(GO:0009726) response to high density lipoprotein particle(GO:0055099) |
| 1.9 | 17.0 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 1.9 | 17.0 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 1.9 | 64.0 | GO:0006706 | steroid catabolic process(GO:0006706) |
| 1.9 | 11.3 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 1.9 | 32.0 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
| 1.9 | 7.5 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
| 1.9 | 3.7 | GO:0010652 | regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
| 1.9 | 35.5 | GO:0071625 | vocalization behavior(GO:0071625) |
| 1.9 | 5.6 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
| 1.9 | 5.6 | GO:0071494 | cellular response to UV-C(GO:0071494) |
| 1.8 | 11.0 | GO:0051012 | microtubule sliding(GO:0051012) |
| 1.8 | 5.5 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
| 1.8 | 3.7 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 1.8 | 1.8 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
| 1.8 | 5.5 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
| 1.8 | 12.8 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 1.8 | 1.8 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
| 1.8 | 18.3 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
| 1.8 | 5.5 | GO:1902530 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 1.8 | 5.5 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
| 1.8 | 5.4 | GO:2001271 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 1.8 | 23.4 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
| 1.8 | 12.6 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
| 1.8 | 3.6 | GO:0015808 | L-alanine transport(GO:0015808) |
| 1.8 | 9.0 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 1.8 | 1.8 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
| 1.8 | 17.9 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 1.8 | 1.8 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
| 1.8 | 5.4 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
| 1.8 | 7.2 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
| 1.8 | 17.9 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 1.8 | 10.7 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 1.8 | 3.6 | GO:0015670 | carbon dioxide transport(GO:0015670) |
| 1.8 | 1.8 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
| 1.8 | 1.8 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
| 1.8 | 1.8 | GO:0032455 | nerve growth factor processing(GO:0032455) |
| 1.8 | 3.6 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 1.8 | 16.0 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 1.8 | 5.3 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 1.8 | 7.1 | GO:0071233 | cellular response to leucine(GO:0071233) |
| 1.8 | 1.8 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
| 1.8 | 14.0 | GO:0060025 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) regulation of synaptic activity(GO:0060025) |
| 1.8 | 5.3 | GO:0021778 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 1.7 | 5.2 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
| 1.7 | 5.2 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 1.7 | 5.2 | GO:0021678 | fourth ventricle development(GO:0021592) third ventricle development(GO:0021678) |
| 1.7 | 3.4 | GO:0030035 | microspike assembly(GO:0030035) |
| 1.7 | 8.6 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
| 1.7 | 3.4 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
| 1.7 | 8.6 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
| 1.7 | 3.4 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
| 1.7 | 1.7 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 1.7 | 29.2 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
| 1.7 | 6.9 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 1.7 | 6.8 | GO:2000864 | estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) regulation of estradiol secretion(GO:2000864) |
| 1.7 | 8.5 | GO:0043126 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 1.7 | 3.4 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
| 1.7 | 27.2 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
| 1.7 | 27.2 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
| 1.7 | 15.3 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 1.7 | 13.5 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) |
| 1.7 | 3.4 | GO:0070842 | aggresome assembly(GO:0070842) |
| 1.7 | 116.5 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
| 1.7 | 62.4 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
| 1.7 | 15.2 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 1.7 | 1.7 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
| 1.7 | 6.7 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
| 1.7 | 5.0 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 1.7 | 6.7 | GO:1903627 | regulation of calcium-dependent ATPase activity(GO:1903610) negative regulation of calcium-dependent ATPase activity(GO:1903611) regulation of dUTP diphosphatase activity(GO:1903627) positive regulation of dUTP diphosphatase activity(GO:1903629) negative regulation of aminoacyl-tRNA ligase activity(GO:1903631) regulation of leucine-tRNA ligase activity(GO:1903633) negative regulation of leucine-tRNA ligase activity(GO:1903634) |
| 1.7 | 3.4 | GO:0048840 | otolith development(GO:0048840) |
| 1.7 | 21.8 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) |
| 1.7 | 5.0 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 1.7 | 16.7 | GO:0035493 | SNARE complex assembly(GO:0035493) |
| 1.7 | 1.7 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 1.7 | 46.5 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 1.7 | 86.1 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 1.7 | 5.0 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
| 1.7 | 5.0 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) positive regulation of anion transmembrane transport(GO:1903961) |
| 1.6 | 4.9 | GO:0034183 | negative regulation of maintenance of sister chromatid cohesion(GO:0034092) negative regulation of maintenance of mitotic sister chromatid cohesion(GO:0034183) maintenance of mitotic sister chromatid cohesion, telomeric(GO:0099403) mitotic sister chromatid cohesion, telomeric(GO:0099404) regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904907) negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904908) |
| 1.6 | 4.9 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) fat-soluble vitamin catabolic process(GO:0042363) |
| 1.6 | 49.1 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
| 1.6 | 3.3 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 1.6 | 4.9 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
| 1.6 | 6.5 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) |
| 1.6 | 9.7 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
| 1.6 | 1.6 | GO:1902949 | positive regulation of tau-protein kinase activity(GO:1902949) |
| 1.6 | 27.4 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
| 1.6 | 8.0 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
| 1.6 | 11.2 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
| 1.6 | 1.6 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
| 1.6 | 17.5 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
| 1.6 | 25.5 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
| 1.6 | 4.8 | GO:2000521 | negative regulation of immunological synapse formation(GO:2000521) |
| 1.6 | 6.3 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) |
| 1.6 | 14.2 | GO:0021794 | thalamus development(GO:0021794) |
| 1.6 | 1.6 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
| 1.6 | 4.7 | GO:0071988 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
| 1.6 | 11.0 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 1.6 | 7.9 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
| 1.6 | 111.2 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
| 1.6 | 3.1 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
| 1.6 | 7.8 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 1.6 | 17.1 | GO:0007413 | axonal fasciculation(GO:0007413) |
| 1.5 | 29.3 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 1.5 | 3.1 | GO:0006566 | threonine metabolic process(GO:0006566) |
| 1.5 | 19.9 | GO:0071318 | cellular response to ATP(GO:0071318) |
| 1.5 | 6.1 | GO:0042182 | ketone catabolic process(GO:0042182) |
| 1.5 | 1.5 | GO:0014048 | regulation of glutamate secretion(GO:0014048) |
| 1.5 | 7.6 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
| 1.5 | 1.5 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 1.5 | 13.6 | GO:1901678 | iron coordination entity transport(GO:1901678) |
| 1.5 | 6.0 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 1.5 | 9.0 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 1.5 | 4.5 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
| 1.5 | 43.4 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 1.5 | 6.0 | GO:0042574 | retinal metabolic process(GO:0042574) |
| 1.5 | 19.4 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 1.5 | 37.2 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 1.5 | 1.5 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
| 1.5 | 7.4 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
| 1.5 | 5.9 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
| 1.5 | 27.8 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
| 1.5 | 4.4 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
| 1.5 | 13.1 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 1.4 | 1.4 | GO:0045792 | negative regulation of cell size(GO:0045792) |
| 1.4 | 13.0 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 1.4 | 2.9 | GO:0035900 | response to isolation stress(GO:0035900) |
| 1.4 | 4.3 | GO:0006114 | glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
| 1.4 | 11.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 1.4 | 30.1 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
| 1.4 | 7.1 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
| 1.4 | 2.8 | GO:0072176 | nephric duct development(GO:0072176) |
| 1.4 | 31.2 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 1.4 | 2.8 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 1.4 | 4.2 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
| 1.4 | 9.8 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
| 1.4 | 4.2 | GO:2000830 | vacuolar phosphate transport(GO:0007037) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
| 1.4 | 14.0 | GO:0006068 | ethanol catabolic process(GO:0006068) |
| 1.4 | 14.0 | GO:0015871 | choline transport(GO:0015871) |
| 1.4 | 15.3 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) |
| 1.4 | 2.8 | GO:0061526 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
| 1.4 | 20.8 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
| 1.4 | 11.1 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 1.4 | 1.4 | GO:0023021 | termination of signal transduction(GO:0023021) |
| 1.4 | 11.0 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 1.4 | 4.1 | GO:0052422 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
| 1.4 | 5.5 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
| 1.4 | 15.0 | GO:0008038 | neuron recognition(GO:0008038) |
| 1.4 | 5.5 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 1.4 | 10.9 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 1.4 | 24.5 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 1.4 | 1.4 | GO:0010615 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 1.3 | 5.4 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
| 1.3 | 27.0 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
| 1.3 | 2.7 | GO:0008354 | germ cell migration(GO:0008354) |
| 1.3 | 5.4 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
| 1.3 | 2.7 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 1.3 | 41.5 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
| 1.3 | 38.8 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 1.3 | 8.0 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
| 1.3 | 5.3 | GO:0061582 | intestinal epithelial cell migration(GO:0061582) |
| 1.3 | 9.3 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
| 1.3 | 1.3 | GO:0032328 | alanine transport(GO:0032328) |
| 1.3 | 19.8 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
| 1.3 | 2.6 | GO:1904435 | regulation of T cell antigen processing and presentation(GO:0002625) positive regulation of iron ion transport(GO:0034758) positive regulation of iron ion transmembrane transport(GO:0034761) regulation of iron ion import(GO:1900390) regulation of ferrous iron import into cell(GO:1903989) positive regulation of ferrous iron import into cell(GO:1903991) regulation of ferrous iron binding(GO:1904432) positive regulation of ferrous iron binding(GO:1904434) regulation of transferrin receptor binding(GO:1904435) positive regulation of transferrin receptor binding(GO:1904437) regulation of ferrous iron import across plasma membrane(GO:1904438) positive regulation of ferrous iron import across plasma membrane(GO:1904440) |
| 1.3 | 22.3 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
| 1.3 | 22.3 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) |
| 1.3 | 6.6 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
| 1.3 | 6.6 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 1.3 | 7.8 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 1.3 | 2.6 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
| 1.3 | 3.9 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 1.3 | 9.1 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
| 1.3 | 9.1 | GO:0048243 | norepinephrine secretion(GO:0048243) |
| 1.3 | 7.8 | GO:0016926 | protein desumoylation(GO:0016926) |
| 1.3 | 1.3 | GO:0021533 | cell differentiation in hindbrain(GO:0021533) |
| 1.3 | 2.6 | GO:0048865 | stem cell fate commitment(GO:0048865) |
| 1.3 | 18.0 | GO:0007220 | Notch receptor processing(GO:0007220) |
| 1.3 | 3.8 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
| 1.3 | 21.6 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
| 1.3 | 29.0 | GO:0014047 | glutamate secretion(GO:0014047) |
| 1.3 | 5.1 | GO:0071440 | regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 1.3 | 6.3 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
| 1.3 | 18.8 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 1.3 | 31.3 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
| 1.2 | 38.6 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
| 1.2 | 73.0 | GO:0001578 | microtubule bundle formation(GO:0001578) |
| 1.2 | 4.9 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 1.2 | 3.7 | GO:0070625 | zymogen granule exocytosis(GO:0070625) |
| 1.2 | 1.2 | GO:2001293 | malonyl-CoA metabolic process(GO:2001293) |
| 1.2 | 8.6 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 1.2 | 9.7 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
| 1.2 | 6.0 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
| 1.2 | 8.4 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
| 1.2 | 4.8 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 1.2 | 4.8 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
| 1.2 | 6.0 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 1.2 | 16.6 | GO:0021978 | telencephalon regionalization(GO:0021978) |
| 1.2 | 1.2 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
| 1.2 | 2.4 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
| 1.2 | 2.4 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
| 1.2 | 2.3 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
| 1.2 | 10.5 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
| 1.2 | 1.2 | GO:1903960 | negative regulation of anion transmembrane transport(GO:1903960) |
| 1.2 | 4.7 | GO:0090260 | negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
| 1.2 | 3.5 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 1.2 | 3.5 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
| 1.2 | 7.0 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
| 1.1 | 9.2 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 1.1 | 1.1 | GO:0010543 | regulation of platelet activation(GO:0010543) |
| 1.1 | 4.6 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
| 1.1 | 4.5 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 1.1 | 1.1 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
| 1.1 | 5.7 | GO:1990403 | embryonic brain development(GO:1990403) |
| 1.1 | 1.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
| 1.1 | 1.1 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 1.1 | 5.6 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
| 1.1 | 2.2 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
| 1.1 | 6.6 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
| 1.1 | 1.1 | GO:0002265 | astrocyte activation involved in immune response(GO:0002265) |
| 1.1 | 8.8 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 1.1 | 24.2 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 1.1 | 3.3 | GO:0002086 | diaphragm contraction(GO:0002086) |
| 1.1 | 3.3 | GO:0060152 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 1.1 | 1.1 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
| 1.1 | 2.2 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
| 1.1 | 16.2 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
| 1.1 | 1.1 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
| 1.1 | 3.2 | GO:0071529 | cementum mineralization(GO:0071529) |
| 1.1 | 1.1 | GO:0009111 | vitamin catabolic process(GO:0009111) |
| 1.1 | 4.2 | GO:0060022 | hard palate development(GO:0060022) |
| 1.1 | 19.0 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
| 1.0 | 6.3 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
| 1.0 | 1.0 | GO:0035502 | metanephric part of ureteric bud development(GO:0035502) |
| 1.0 | 1.0 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 1.0 | 7.3 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
| 1.0 | 1.0 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
| 1.0 | 4.2 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 1.0 | 13.6 | GO:0034063 | stress granule assembly(GO:0034063) |
| 1.0 | 7.3 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 1.0 | 1.0 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
| 1.0 | 54.6 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 1.0 | 2.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 1.0 | 2.0 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 1.0 | 5.1 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
| 1.0 | 3.1 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 1.0 | 11.1 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 1.0 | 10.0 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
| 1.0 | 3.0 | GO:0045212 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 1.0 | 5.0 | GO:0090043 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
| 1.0 | 24.7 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
| 1.0 | 1.0 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) regulation of skeletal muscle tissue growth(GO:0048631) |
| 1.0 | 3.9 | GO:0036010 | protein localization to endosome(GO:0036010) |
| 1.0 | 6.9 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 1.0 | 2.9 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
| 1.0 | 3.9 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
| 1.0 | 1.0 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
| 1.0 | 21.3 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
| 1.0 | 3.9 | GO:0031627 | telomeric loop formation(GO:0031627) |
| 1.0 | 1.0 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
| 1.0 | 10.6 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 1.0 | 1.9 | GO:0003352 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
| 1.0 | 55.5 | GO:0046847 | filopodium assembly(GO:0046847) |
| 1.0 | 18.2 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
| 1.0 | 13.4 | GO:0046697 | decidualization(GO:0046697) |
| 1.0 | 3.8 | GO:2000569 | T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
| 1.0 | 7.6 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.9 | 0.9 | GO:1990502 | dense core granule maturation(GO:1990502) |
| 0.9 | 3.8 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
| 0.9 | 5.7 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.9 | 4.7 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.9 | 2.8 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.9 | 3.8 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.9 | 2.8 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
| 0.9 | 12.1 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.9 | 9.3 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.9 | 5.6 | GO:0046710 | GDP metabolic process(GO:0046710) |
| 0.9 | 23.1 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.9 | 3.7 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
| 0.9 | 16.5 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
| 0.9 | 1.8 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
| 0.9 | 58.3 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
| 0.9 | 3.6 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
| 0.9 | 11.8 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
| 0.9 | 0.9 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
| 0.9 | 0.9 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 0.9 | 18.8 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 0.9 | 0.9 | GO:1903056 | regulation of melanosome organization(GO:1903056) |
| 0.9 | 2.7 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
| 0.9 | 6.3 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.9 | 4.5 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
| 0.9 | 72.8 | GO:0090630 | activation of GTPase activity(GO:0090630) |
| 0.9 | 5.3 | GO:0071105 | response to interleukin-11(GO:0071105) |
| 0.9 | 6.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.9 | 3.5 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.9 | 4.4 | GO:0090383 | phagosome acidification(GO:0090383) |
| 0.9 | 0.9 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.9 | 2.6 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
| 0.9 | 3.5 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
| 0.9 | 6.1 | GO:0060004 | reflex(GO:0060004) |
| 0.9 | 3.5 | GO:0090662 | ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.9 | 6.0 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
| 0.9 | 4.3 | GO:0002076 | osteoblast development(GO:0002076) |
| 0.9 | 2.6 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.8 | 5.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.8 | 18.7 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
| 0.8 | 8.5 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.8 | 16.0 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
| 0.8 | 5.9 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.8 | 5.0 | GO:0001705 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
| 0.8 | 1.7 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
| 0.8 | 5.0 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
| 0.8 | 11.6 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.8 | 0.8 | GO:1904954 | canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
| 0.8 | 4.1 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.8 | 0.8 | GO:1903626 | positive regulation of DNA catabolic process(GO:1903626) |
| 0.8 | 5.0 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.8 | 0.8 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
| 0.8 | 9.9 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.8 | 46.1 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
| 0.8 | 2.5 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.8 | 13.0 | GO:0010842 | retina layer formation(GO:0010842) |
| 0.8 | 1.6 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
| 0.8 | 9.7 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.8 | 4.8 | GO:0006489 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
| 0.8 | 3.2 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
| 0.8 | 2.4 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
| 0.8 | 13.5 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 0.8 | 3.2 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
| 0.8 | 1.6 | GO:2000584 | regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
| 0.8 | 10.3 | GO:0036124 | histone H3-K9 trimethylation(GO:0036124) |
| 0.8 | 5.5 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.8 | 3.1 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.8 | 1.6 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
| 0.8 | 0.8 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.8 | 0.8 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
| 0.8 | 5.4 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.8 | 10.0 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
| 0.8 | 3.1 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
| 0.8 | 1.5 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 0.8 | 18.3 | GO:0007041 | lysosomal transport(GO:0007041) |
| 0.8 | 28.1 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.8 | 2.3 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 0.8 | 5.3 | GO:0045176 | apical protein localization(GO:0045176) |
| 0.8 | 46.1 | GO:0030516 | regulation of axon extension(GO:0030516) |
| 0.8 | 1.5 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
| 0.7 | 4.5 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.7 | 0.7 | GO:0060423 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) regulation of branching involved in lung morphogenesis(GO:0061046) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
| 0.7 | 0.7 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
| 0.7 | 11.8 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.7 | 6.6 | GO:0043302 | positive regulation of leukocyte degranulation(GO:0043302) |
| 0.7 | 2.2 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
| 0.7 | 4.4 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.7 | 2.2 | GO:1900155 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 0.7 | 3.7 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.7 | 2.2 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.7 | 2.2 | GO:0006683 | galactosylceramide catabolic process(GO:0006683) |
| 0.7 | 5.8 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.7 | 16.0 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
| 0.7 | 17.4 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
| 0.7 | 1.5 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 0.7 | 1.5 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
| 0.7 | 3.6 | GO:0031112 | positive regulation of microtubule polymerization or depolymerization(GO:0031112) positive regulation of microtubule polymerization(GO:0031116) |
| 0.7 | 2.2 | GO:0051232 | meiotic spindle elongation(GO:0051232) meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
| 0.7 | 7.8 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.7 | 0.7 | GO:2001023 | regulation of response to drug(GO:2001023) |
| 0.7 | 2.8 | GO:1904379 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 0.7 | 2.1 | GO:0090107 | regulation of high-density lipoprotein particle assembly(GO:0090107) |
| 0.7 | 1.4 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
| 0.7 | 4.2 | GO:0042755 | eating behavior(GO:0042755) |
| 0.7 | 16.1 | GO:0097502 | mannosylation(GO:0097502) |
| 0.7 | 1.4 | GO:0086053 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.7 | 11.2 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.7 | 0.7 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.7 | 4.9 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
| 0.7 | 2.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.7 | 5.6 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.7 | 2.1 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
| 0.7 | 2.8 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
| 0.7 | 4.8 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.7 | 2.1 | GO:0061511 | centriole elongation(GO:0061511) |
| 0.7 | 2.7 | GO:1903173 | phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
| 0.7 | 2.0 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
| 0.7 | 0.7 | GO:0060005 | vestibular reflex(GO:0060005) |
| 0.7 | 19.7 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.7 | 2.0 | GO:0045957 | regulation of complement activation, alternative pathway(GO:0030451) negative regulation of complement activation, alternative pathway(GO:0045957) |
| 0.7 | 6.7 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
| 0.7 | 2.7 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
| 0.7 | 2.0 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.7 | 4.7 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.7 | 3.4 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
| 0.7 | 1.3 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
| 0.7 | 2.7 | GO:0002880 | chronic inflammatory response to non-antigenic stimulus(GO:0002545) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
| 0.7 | 6.0 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
| 0.7 | 12.6 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
| 0.7 | 1.3 | GO:0021843 | substrate-independent telencephalic tangential migration(GO:0021826) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
| 0.7 | 0.7 | GO:0001796 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) |
| 0.7 | 31.6 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
| 0.7 | 0.7 | GO:0072313 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 0.7 | 1.3 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 0.7 | 18.3 | GO:0010107 | potassium ion import(GO:0010107) |
| 0.7 | 0.7 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
| 0.7 | 2.6 | GO:0001842 | neural fold formation(GO:0001842) |
| 0.6 | 0.6 | GO:0002029 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
| 0.6 | 24.6 | GO:0007528 | neuromuscular junction development(GO:0007528) |
| 0.6 | 0.6 | GO:0050666 | regulation of sulfur amino acid metabolic process(GO:0031335) regulation of homocysteine metabolic process(GO:0050666) |
| 0.6 | 1.3 | GO:0097484 | dendrite extension(GO:0097484) |
| 0.6 | 3.2 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
| 0.6 | 1.9 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
| 0.6 | 3.9 | GO:0006983 | ER overload response(GO:0006983) |
| 0.6 | 3.8 | GO:0060157 | urinary bladder development(GO:0060157) |
| 0.6 | 3.2 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.6 | 3.8 | GO:0070375 | ERK5 cascade(GO:0070375) |
| 0.6 | 3.8 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.6 | 2.5 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.6 | 10.6 | GO:0014850 | response to muscle activity(GO:0014850) |
| 0.6 | 2.5 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
| 0.6 | 1.2 | GO:1901626 | regulation of postsynaptic membrane organization(GO:1901626) |
| 0.6 | 18.5 | GO:0090102 | cochlea development(GO:0090102) |
| 0.6 | 1.2 | GO:1990637 | response to prolactin(GO:1990637) |
| 0.6 | 0.6 | GO:0044321 | response to leptin(GO:0044321) |
| 0.6 | 1.8 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
| 0.6 | 32.3 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
| 0.6 | 0.6 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.6 | 2.4 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.6 | 55.2 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
| 0.6 | 3.5 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.6 | 28.5 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
| 0.6 | 5.8 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
| 0.6 | 2.9 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
| 0.6 | 5.7 | GO:0070633 | transepithelial transport(GO:0070633) |
| 0.6 | 53.0 | GO:0006813 | potassium ion transport(GO:0006813) |
| 0.6 | 1.1 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
| 0.6 | 2.3 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.6 | 2.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 0.6 | 1.7 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
| 0.6 | 2.2 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) |
| 0.6 | 1.1 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
| 0.6 | 5.6 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.6 | 2.8 | GO:0015692 | lead ion transport(GO:0015692) |
| 0.6 | 8.8 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
| 0.6 | 0.6 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.5 | 3.3 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.5 | 4.4 | GO:0060292 | long term synaptic depression(GO:0060292) |
| 0.5 | 1.1 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.5 | 6.0 | GO:0097503 | sialylation(GO:0097503) |
| 0.5 | 5.4 | GO:0021854 | hypothalamus development(GO:0021854) |
| 0.5 | 5.9 | GO:0090314 | positive regulation of protein targeting to membrane(GO:0090314) |
| 0.5 | 2.7 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.5 | 0.5 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
| 0.5 | 2.1 | GO:0015705 | iodide transport(GO:0015705) |
| 0.5 | 5.2 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.5 | 3.1 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
| 0.5 | 2.6 | GO:0032264 | IMP salvage(GO:0032264) |
| 0.5 | 1.0 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
| 0.5 | 0.5 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.5 | 15.8 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
| 0.5 | 4.4 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
| 0.5 | 5.3 | GO:0044458 | motile cilium assembly(GO:0044458) |
| 0.5 | 3.9 | GO:0070236 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.5 | 1.9 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.5 | 1.9 | GO:0051037 | regulation of transcription involved in meiotic cell cycle(GO:0051037) |
| 0.5 | 1.0 | GO:0010587 | miRNA catabolic process(GO:0010587) |
| 0.5 | 1.9 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
| 0.5 | 2.4 | GO:1901563 | response to camptothecin(GO:1901563) |
| 0.5 | 1.9 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.5 | 4.3 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
| 0.5 | 3.8 | GO:0060009 | Sertoli cell development(GO:0060009) |
| 0.5 | 0.5 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
| 0.5 | 4.7 | GO:0050820 | positive regulation of blood coagulation(GO:0030194) positive regulation of coagulation(GO:0050820) positive regulation of hemostasis(GO:1900048) |
| 0.5 | 0.9 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
| 0.5 | 1.4 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 0.5 | 1.4 | GO:0032700 | negative regulation of interleukin-17 production(GO:0032700) |
| 0.5 | 0.5 | GO:0008088 | axo-dendritic transport(GO:0008088) |
| 0.5 | 1.8 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
| 0.4 | 1.8 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.4 | 4.5 | GO:0000022 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
| 0.4 | 2.7 | GO:0032026 | response to magnesium ion(GO:0032026) |
| 0.4 | 4.0 | GO:0010518 | positive regulation of phospholipase activity(GO:0010518) |
| 0.4 | 0.4 | GO:0052173 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) response to host(GO:0075136) |
| 0.4 | 0.4 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
| 0.4 | 2.2 | GO:0036089 | cleavage furrow formation(GO:0036089) |
| 0.4 | 1.7 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.4 | 0.9 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal lipid absorption(GO:1904729) |
| 0.4 | 1.3 | GO:0002384 | hepatic immune response(GO:0002384) |
| 0.4 | 3.9 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.4 | 3.4 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.4 | 0.4 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 0.4 | 1.7 | GO:2000848 | positive regulation of corticosteroid hormone secretion(GO:2000848) |
| 0.4 | 2.1 | GO:0010447 | response to acidic pH(GO:0010447) |
| 0.4 | 27.3 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.4 | 0.4 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.4 | 0.8 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
| 0.4 | 2.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.4 | 0.4 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
| 0.4 | 1.3 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 0.4 | 4.2 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.4 | 0.4 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
| 0.4 | 0.8 | GO:0071462 | positive regulation of anagen(GO:0051885) cellular response to water stimulus(GO:0071462) cellular response to hydrostatic pressure(GO:0071464) |
| 0.4 | 1.2 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.4 | 0.4 | GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
| 0.4 | 1.2 | GO:0009386 | translational attenuation(GO:0009386) |
| 0.4 | 0.8 | GO:0044804 | nucleophagy(GO:0044804) |
| 0.4 | 0.8 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 0.4 | 1.2 | GO:0061217 | regulation of mesonephros development(GO:0061217) regulation of branching involved in ureteric bud morphogenesis(GO:0090189) |
| 0.4 | 3.6 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
| 0.4 | 2.8 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
| 0.4 | 1.2 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
| 0.4 | 0.8 | GO:1900239 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 0.4 | 6.7 | GO:0006590 | thyroid hormone generation(GO:0006590) |
| 0.4 | 3.6 | GO:0042417 | dopamine metabolic process(GO:0042417) |
| 0.4 | 4.7 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
| 0.4 | 3.9 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
| 0.4 | 0.8 | GO:1903351 | response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
| 0.4 | 6.5 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
| 0.4 | 14.2 | GO:0007269 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
| 0.4 | 0.4 | GO:0036079 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.4 | 1.9 | GO:0031645 | negative regulation of myelination(GO:0031642) negative regulation of neurological system process(GO:0031645) |
| 0.4 | 2.3 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.4 | 0.8 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.4 | 1.9 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
| 0.4 | 0.4 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.4 | 0.4 | GO:2000410 | tolerance induction dependent upon immune response(GO:0002461) regulation of thymocyte migration(GO:2000410) |
| 0.4 | 2.2 | GO:0014044 | Schwann cell development(GO:0014044) |
| 0.4 | 0.4 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
| 0.4 | 3.3 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
| 0.4 | 1.8 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.4 | 4.1 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
| 0.4 | 6.6 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
| 0.4 | 0.4 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
| 0.4 | 2.6 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
| 0.4 | 0.4 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
| 0.4 | 1.1 | GO:0019046 | release from viral latency(GO:0019046) |
| 0.4 | 3.3 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.4 | 1.1 | GO:0014876 | response to injury involved in regulation of muscle adaptation(GO:0014876) |
| 0.4 | 1.8 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
| 0.4 | 4.3 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.4 | 5.7 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.4 | 5.7 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
| 0.4 | 3.2 | GO:0030539 | male genitalia development(GO:0030539) |
| 0.4 | 1.1 | GO:0006788 | heme oxidation(GO:0006788) |
| 0.4 | 3.5 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
| 0.4 | 9.8 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
| 0.3 | 0.3 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.3 | 1.4 | GO:0046968 | peptide antigen transport(GO:0046968) |
| 0.3 | 1.7 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.3 | 3.1 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
| 0.3 | 6.3 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
| 0.3 | 1.3 | GO:0071600 | otic vesicle morphogenesis(GO:0071600) |
| 0.3 | 0.7 | GO:0006772 | thiamine metabolic process(GO:0006772) |
| 0.3 | 1.0 | GO:1902572 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.3 | 1.0 | GO:0015847 | putrescine transport(GO:0015847) |
| 0.3 | 0.3 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 0.3 | 0.6 | GO:0006726 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.3 | 1.0 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) growth plate cartilage chondrocyte development(GO:0003431) |
| 0.3 | 0.3 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.3 | 0.6 | GO:0021697 | cerebellar cortex formation(GO:0021697) |
| 0.3 | 0.3 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
| 0.3 | 1.2 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.3 | 0.6 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
| 0.3 | 0.6 | GO:0072223 | metanephric glomerular mesangium development(GO:0072223) |
| 0.3 | 0.9 | GO:0042756 | drinking behavior(GO:0042756) |
| 0.3 | 113.3 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
| 0.3 | 0.6 | GO:0014745 | negative regulation of muscle adaptation(GO:0014745) |
| 0.3 | 1.2 | GO:0045023 | G0 to G1 transition(GO:0045023) |
| 0.3 | 2.0 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
| 0.3 | 2.0 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
| 0.3 | 1.4 | GO:0021544 | subpallium development(GO:0021544) |
| 0.3 | 0.3 | GO:0021984 | adenohypophysis development(GO:0021984) |
| 0.3 | 6.8 | GO:0030488 | tRNA methylation(GO:0030488) |
| 0.3 | 0.3 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
| 0.3 | 0.3 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
| 0.3 | 0.8 | GO:0060042 | retina morphogenesis in camera-type eye(GO:0060042) |
| 0.3 | 2.7 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.3 | 0.8 | GO:0014003 | oligodendrocyte development(GO:0014003) |
| 0.3 | 0.3 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
| 0.3 | 0.8 | GO:0035803 | egg coat formation(GO:0035803) |
| 0.3 | 0.8 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
| 0.3 | 2.1 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
| 0.3 | 9.4 | GO:0050909 | sensory perception of taste(GO:0050909) |
| 0.3 | 2.6 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.3 | 0.3 | GO:0033194 | response to hydroperoxide(GO:0033194) |
| 0.3 | 1.5 | GO:0007398 | ectoderm development(GO:0007398) |
| 0.3 | 5.4 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
| 0.3 | 2.5 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
| 0.2 | 3.2 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
| 0.2 | 0.5 | GO:0003211 | cardiac ventricle formation(GO:0003211) |
| 0.2 | 1.2 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.2 | 0.7 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
| 0.2 | 1.5 | GO:0006196 | AMP catabolic process(GO:0006196) |
| 0.2 | 0.7 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
| 0.2 | 0.5 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
| 0.2 | 1.9 | GO:0046548 | retinal rod cell development(GO:0046548) |
| 0.2 | 1.6 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 0.2 | 2.3 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.2 | 0.9 | GO:0032494 | response to peptidoglycan(GO:0032494) |
| 0.2 | 0.5 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
| 0.2 | 3.2 | GO:0045026 | plasma membrane fusion(GO:0045026) |
| 0.2 | 2.5 | GO:0006552 | leucine catabolic process(GO:0006552) |
| 0.2 | 2.9 | GO:0048820 | hair follicle maturation(GO:0048820) |
| 0.2 | 1.8 | GO:0071569 | protein ufmylation(GO:0071569) |
| 0.2 | 1.1 | GO:0093001 | glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
| 0.2 | 1.7 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
| 0.2 | 0.6 | GO:0006780 | uroporphyrinogen III biosynthetic process(GO:0006780) succinyl-CoA pathway(GO:0006781) uroporphyrinogen III metabolic process(GO:0046502) |
| 0.2 | 1.5 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.2 | 0.2 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 0.2 | 5.7 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
| 0.2 | 3.1 | GO:0032418 | lysosome localization(GO:0032418) |
| 0.2 | 6.8 | GO:0043507 | positive regulation of JUN kinase activity(GO:0043507) |
| 0.2 | 0.4 | GO:0043379 | memory T cell differentiation(GO:0043379) |
| 0.2 | 0.6 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
| 0.2 | 0.4 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
| 0.2 | 0.4 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
| 0.2 | 0.6 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.2 | 1.2 | GO:0051026 | chiasma assembly(GO:0051026) |
| 0.2 | 1.0 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
| 0.2 | 1.9 | GO:0042355 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.2 | 4.0 | GO:0035303 | regulation of dephosphorylation(GO:0035303) |
| 0.2 | 0.4 | GO:0060174 | limb bud formation(GO:0060174) |
| 0.2 | 1.3 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
| 0.2 | 1.5 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
| 0.2 | 0.2 | GO:0003177 | pulmonary valve development(GO:0003177) pulmonary valve morphogenesis(GO:0003184) |
| 0.2 | 0.7 | GO:0060068 | vagina development(GO:0060068) |
| 0.2 | 0.5 | GO:0002818 | intracellular defense response(GO:0002818) |
| 0.2 | 0.2 | GO:0002448 | mast cell mediated immunity(GO:0002448) |
| 0.2 | 0.9 | GO:0002775 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
| 0.2 | 0.5 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 0.2 | 0.5 | GO:0071351 | interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
| 0.2 | 0.3 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.2 | 2.7 | GO:0051004 | regulation of lipoprotein lipase activity(GO:0051004) |
| 0.2 | 4.9 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
| 0.2 | 1.2 | GO:0015874 | norepinephrine transport(GO:0015874) |
| 0.2 | 1.3 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
| 0.2 | 0.2 | GO:1900673 | olefin metabolic process(GO:1900673) |
| 0.2 | 0.3 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
| 0.2 | 0.6 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
| 0.2 | 1.1 | GO:0097576 | vacuole fusion(GO:0097576) |
| 0.2 | 0.5 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.2 | 0.3 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
| 0.2 | 0.6 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.1 | 0.9 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.1 | 0.1 | GO:0050746 | regulation of lipoprotein metabolic process(GO:0050746) |
| 0.1 | 0.6 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
| 0.1 | 0.3 | GO:0042711 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
| 0.1 | 0.8 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
| 0.1 | 0.4 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
| 0.1 | 0.1 | GO:0043545 | molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
| 0.1 | 0.8 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
| 0.1 | 1.5 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.1 | 1.5 | GO:0021782 | glial cell development(GO:0021782) |
| 0.1 | 0.9 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
| 0.1 | 0.7 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
| 0.1 | 1.1 | GO:0010996 | response to auditory stimulus(GO:0010996) |
| 0.1 | 1.1 | GO:0009597 | detection of virus(GO:0009597) |
| 0.1 | 0.1 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
| 0.1 | 0.4 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
| 0.1 | 0.4 | GO:0060119 | inner ear receptor cell development(GO:0060119) |
| 0.1 | 1.9 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
| 0.1 | 10.1 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
| 0.1 | 0.5 | GO:0036100 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 0.1 | 0.6 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
| 0.1 | 0.7 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
| 0.1 | 1.1 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
| 0.1 | 0.4 | GO:0010002 | cardioblast differentiation(GO:0010002) |
| 0.1 | 0.6 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.1 | 0.1 | GO:0032099 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 0.1 | 0.2 | GO:0032571 | response to vitamin K(GO:0032571) |
| 0.1 | 7.8 | GO:0019886 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
| 0.1 | 0.1 | GO:0035933 | glucocorticoid secretion(GO:0035933) regulation of glucocorticoid secretion(GO:2000849) |
| 0.1 | 1.8 | GO:0014889 | muscle atrophy(GO:0014889) |
| 0.1 | 1.2 | GO:0048240 | sperm capacitation(GO:0048240) |
| 0.1 | 0.2 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.1 | 0.6 | GO:0090197 | positive regulation of chemokine secretion(GO:0090197) |
| 0.1 | 1.1 | GO:0050919 | negative chemotaxis(GO:0050919) |
| 0.1 | 0.3 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.1 | 0.5 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.1 | 0.1 | GO:0019878 | lysine biosynthetic process(GO:0009085) lysine biosynthetic process via aminoadipic acid(GO:0019878) |
| 0.1 | 0.5 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
| 0.1 | 0.2 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
| 0.1 | 0.2 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
| 0.1 | 0.1 | GO:0036018 | cellular response to erythropoietin(GO:0036018) |
| 0.1 | 0.4 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.1 | 0.8 | GO:0008053 | mitochondrial fusion(GO:0008053) |
| 0.1 | 0.5 | GO:0006598 | polyamine catabolic process(GO:0006598) |
| 0.1 | 1.0 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
| 0.1 | 0.1 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
| 0.1 | 0.7 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.1 | 0.6 | GO:0051350 | negative regulation of lyase activity(GO:0051350) |
| 0.1 | 0.2 | GO:0042426 | choline catabolic process(GO:0042426) sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.1 | 0.1 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
| 0.1 | 0.7 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.1 | 0.4 | GO:0032202 | telomere assembly(GO:0032202) |
| 0.1 | 0.3 | GO:0000101 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
| 0.1 | 0.9 | GO:0042461 | photoreceptor cell development(GO:0042461) |
| 0.1 | 0.3 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
| 0.1 | 0.7 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
| 0.1 | 0.3 | GO:0043103 | hypoxanthine salvage(GO:0043103) |
| 0.1 | 1.1 | GO:0052695 | cellular glucuronidation(GO:0052695) |
| 0.1 | 0.1 | GO:0042428 | serotonin metabolic process(GO:0042428) |
| 0.1 | 0.1 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
| 0.1 | 1.0 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
| 0.1 | 0.2 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
| 0.1 | 0.2 | GO:0015942 | formate metabolic process(GO:0015942) histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.1 | 0.1 | GO:0006642 | triglyceride mobilization(GO:0006642) |
| 0.0 | 0.0 | GO:0002005 | angiotensin catabolic process in blood(GO:0002005) multicellular organismal protein catabolic process(GO:0044254) protein digestion(GO:0044256) multicellular organismal macromolecule catabolic process(GO:0044266) |
| 0.0 | 0.1 | GO:1990918 | meiotic DNA double-strand break processing(GO:0000706) double-strand break repair involved in meiotic recombination(GO:1990918) |
| 0.0 | 0.7 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 0.0 | 0.1 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 0.0 | 0.7 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
| 0.0 | 0.1 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.0 | 0.1 | GO:0046689 | response to mercury ion(GO:0046689) |
| 0.0 | 0.2 | GO:0034776 | response to histamine(GO:0034776) |
| 0.0 | 0.1 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.0 | 0.0 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
| 0.0 | 0.0 | GO:0006288 | base-excision repair, DNA ligation(GO:0006288) |
| 0.0 | 0.5 | GO:0006751 | glutathione catabolic process(GO:0006751) leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.0 | 0.1 | GO:0015824 | proline transport(GO:0015824) |
| 0.0 | 0.0 | GO:0050720 | interleukin-1 biosynthetic process(GO:0042222) interleukin-1 beta biosynthetic process(GO:0050720) |
| 0.0 | 0.1 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
| 0.0 | 0.1 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) |
| 0.0 | 0.5 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.0 | 0.0 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
| 0.0 | 0.2 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 0.0 | 0.0 | GO:0060713 | labyrinthine layer morphogenesis(GO:0060713) |
| 0.0 | 0.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.0 | 0.2 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
| 0.0 | 0.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.0 | 0.1 | GO:0048318 | axial mesoderm development(GO:0048318) |
| 0.0 | 0.9 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
| 0.0 | 0.9 | GO:0007187 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger(GO:0007187) |
| 0.0 | 0.3 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
| 0.0 | 0.0 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 0.0 | 0.0 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) |
| 0.0 | 0.0 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
| 0.0 | 0.0 | GO:0060290 | transdifferentiation(GO:0060290) |
| 0.0 | 0.0 | GO:1904528 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
| 0.0 | 0.0 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.0 | 0.1 | GO:0006824 | cobalt ion transport(GO:0006824) |
| 0.0 | 0.1 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
| 0.0 | 0.1 | GO:0003374 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 18.7 | 74.9 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
| 16.3 | 65.2 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
| 15.6 | 46.8 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
| 14.8 | 44.5 | GO:0060987 | lipid tube(GO:0060987) |
| 13.1 | 65.7 | GO:0072534 | perineuronal net(GO:0072534) |
| 12.2 | 73.4 | GO:0033269 | internode region of axon(GO:0033269) |
| 9.1 | 72.9 | GO:0044327 | dendritic spine head(GO:0044327) |
| 8.5 | 76.5 | GO:0098845 | postsynaptic endosome(GO:0098845) |
| 8.5 | 93.1 | GO:0005955 | calcineurin complex(GO:0005955) |
| 8.2 | 32.6 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
| 8.1 | 48.7 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
| 7.9 | 39.4 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
| 7.6 | 30.4 | GO:0070695 | FHF complex(GO:0070695) |
| 7.1 | 28.4 | GO:0019034 | viral replication complex(GO:0019034) |
| 6.7 | 67.3 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 6.7 | 161.1 | GO:0044295 | axonal growth cone(GO:0044295) |
| 6.7 | 33.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 6.6 | 13.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
| 6.5 | 32.7 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
| 6.3 | 18.9 | GO:0016938 | kinesin I complex(GO:0016938) |
| 5.5 | 60.9 | GO:0043203 | axon hillock(GO:0043203) |
| 5.5 | 76.6 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
| 5.3 | 37.0 | GO:1990812 | growth cone filopodium(GO:1990812) |
| 5.2 | 5.2 | GO:0071437 | invadopodium(GO:0071437) |
| 5.2 | 20.6 | GO:0070288 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
| 5.0 | 29.8 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 4.9 | 4.9 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
| 4.9 | 9.8 | GO:0014802 | terminal cisterna(GO:0014802) |
| 4.9 | 14.6 | GO:0099569 | cytoskeleton of presynaptic active zone(GO:0048788) presynaptic active zone cytoplasmic component(GO:0098831) presynaptic cytoskeleton(GO:0099569) |
| 4.8 | 57.2 | GO:0043194 | axon initial segment(GO:0043194) |
| 4.7 | 28.3 | GO:0045298 | tubulin complex(GO:0045298) |
| 4.6 | 96.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 4.4 | 4.4 | GO:0034681 | integrin alpha11-beta1 complex(GO:0034681) |
| 4.4 | 92.6 | GO:0097386 | glial cell projection(GO:0097386) |
| 4.3 | 8.6 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
| 4.3 | 4.3 | GO:0016460 | myosin II complex(GO:0016460) |
| 4.2 | 21.2 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
| 4.1 | 24.7 | GO:0097208 | alveolar lamellar body(GO:0097208) |
| 4.1 | 8.2 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 4.1 | 20.5 | GO:0031673 | H zone(GO:0031673) |
| 4.1 | 45.0 | GO:0033270 | paranode region of axon(GO:0033270) |
| 3.9 | 42.4 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 3.7 | 51.9 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 3.7 | 3.7 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
| 3.6 | 14.5 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
| 3.5 | 42.4 | GO:0097427 | microtubule bundle(GO:0097427) |
| 3.5 | 14.1 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) |
| 3.4 | 20.6 | GO:0032437 | cuticular plate(GO:0032437) |
| 3.4 | 43.9 | GO:0042583 | chromaffin granule(GO:0042583) |
| 3.4 | 81.0 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 3.4 | 10.1 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
| 3.4 | 30.2 | GO:0031209 | SCAR complex(GO:0031209) |
| 3.3 | 10.0 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
| 3.2 | 16.2 | GO:0043291 | RAVE complex(GO:0043291) |
| 3.2 | 12.9 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
| 3.2 | 19.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 3.2 | 291.1 | GO:0043195 | terminal bouton(GO:0043195) |
| 3.1 | 15.7 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 3.1 | 12.5 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 3.1 | 18.5 | GO:0033268 | node of Ranvier(GO:0033268) |
| 3.1 | 58.0 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 3.0 | 82.3 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
| 3.0 | 48.0 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) proton-transporting V-type ATPase, V0 domain(GO:0033179) |
| 3.0 | 26.8 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 3.0 | 17.8 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 3.0 | 165.6 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 2.9 | 147.3 | GO:0043198 | dendritic shaft(GO:0043198) |
| 2.9 | 44.1 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 2.9 | 8.7 | GO:0036398 | TCR signalosome(GO:0036398) |
| 2.9 | 22.9 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
| 2.8 | 31.3 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
| 2.8 | 202.2 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 2.8 | 42.4 | GO:0097433 | dense body(GO:0097433) |
| 2.8 | 19.8 | GO:0033391 | chromatoid body(GO:0033391) |
| 2.8 | 45.0 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 2.8 | 22.5 | GO:0005828 | kinetochore microtubule(GO:0005828) |
| 2.8 | 19.3 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
| 2.7 | 8.0 | GO:0001520 | outer dense fiber(GO:0001520) |
| 2.6 | 20.9 | GO:0035976 | AP1 complex(GO:0035976) |
| 2.6 | 28.6 | GO:0043083 | synaptic cleft(GO:0043083) |
| 2.6 | 5.1 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
| 2.5 | 12.6 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
| 2.3 | 32.5 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
| 2.3 | 7.0 | GO:0034455 | t-UTP complex(GO:0034455) |
| 2.3 | 13.9 | GO:0005594 | collagen type IX trimer(GO:0005594) |
| 2.3 | 739.5 | GO:0060076 | excitatory synapse(GO:0060076) |
| 2.3 | 9.1 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
| 2.3 | 27.0 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 2.2 | 156.4 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
| 2.2 | 8.9 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
| 2.2 | 6.7 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 2.2 | 130.9 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 2.2 | 42.0 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
| 2.2 | 6.6 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
| 2.2 | 8.7 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
| 2.2 | 17.4 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 2.2 | 134.4 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 2.1 | 14.9 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 2.1 | 6.4 | GO:0044609 | DBIRD complex(GO:0044609) |
| 2.1 | 10.4 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
| 2.0 | 6.1 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
| 2.0 | 6.0 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
| 2.0 | 2.0 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
| 1.9 | 13.5 | GO:0005818 | astral microtubule(GO:0000235) aster(GO:0005818) |
| 1.9 | 7.6 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
| 1.9 | 5.7 | GO:0016939 | kinesin II complex(GO:0016939) |
| 1.9 | 11.3 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
| 1.9 | 15.1 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 1.8 | 12.9 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 1.8 | 5.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 1.8 | 37.0 | GO:0030904 | retromer complex(GO:0030904) |
| 1.7 | 51.2 | GO:0005921 | gap junction(GO:0005921) |
| 1.7 | 44.0 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 1.7 | 10.1 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
| 1.7 | 25.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 1.7 | 10.1 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 1.7 | 10.1 | GO:0033655 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
| 1.7 | 6.7 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 1.7 | 5.0 | GO:0032584 | growth cone membrane(GO:0032584) |
| 1.6 | 19.8 | GO:0008091 | spectrin(GO:0008091) |
| 1.6 | 3.3 | GO:0000805 | X chromosome(GO:0000805) |
| 1.6 | 4.9 | GO:0033167 | ARC complex(GO:0033167) |
| 1.6 | 9.8 | GO:0032280 | symmetric synapse(GO:0032280) |
| 1.6 | 3.2 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
| 1.6 | 24.0 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
| 1.6 | 47.6 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 1.6 | 9.4 | GO:0070545 | PeBoW complex(GO:0070545) |
| 1.6 | 6.3 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 1.5 | 23.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 1.5 | 9.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
| 1.5 | 1.5 | GO:0044308 | axonal spine(GO:0044308) |
| 1.5 | 100.0 | GO:0008021 | synaptic vesicle(GO:0008021) |
| 1.5 | 7.5 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 1.5 | 9.0 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 1.5 | 8.9 | GO:0097470 | ribbon synapse(GO:0097470) |
| 1.5 | 53.2 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 1.5 | 26.4 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
| 1.5 | 4.4 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 1.5 | 2.9 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
| 1.5 | 21.9 | GO:0000145 | exocyst(GO:0000145) |
| 1.5 | 7.3 | GO:0036128 | CatSper complex(GO:0036128) |
| 1.4 | 89.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 1.4 | 251.7 | GO:0005802 | trans-Golgi network(GO:0005802) |
| 1.4 | 1.4 | GO:0036020 | endolysosome membrane(GO:0036020) |
| 1.4 | 1.4 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 1.4 | 22.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 1.4 | 9.8 | GO:0097413 | Lewy body(GO:0097413) |
| 1.4 | 2.8 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 1.4 | 9.7 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 1.4 | 5.6 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
| 1.4 | 18.0 | GO:0030478 | actin cap(GO:0030478) |
| 1.4 | 8.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 1.4 | 34.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 1.4 | 125.4 | GO:0034705 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
| 1.4 | 9.5 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 1.4 | 74.3 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 1.3 | 29.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 1.3 | 70.9 | GO:0005771 | multivesicular body(GO:0005771) |
| 1.3 | 1.3 | GO:0002139 | stereocilia coupling link(GO:0002139) |
| 1.3 | 3.9 | GO:0035517 | PR-DUB complex(GO:0035517) |
| 1.3 | 5.2 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 1.3 | 60.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 1.3 | 7.6 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 1.2 | 3.7 | GO:0032116 | SMC loading complex(GO:0032116) |
| 1.2 | 1.2 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
| 1.2 | 11.0 | GO:0005614 | interstitial matrix(GO:0005614) |
| 1.2 | 7.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 1.2 | 4.8 | GO:0035363 | histone locus body(GO:0035363) |
| 1.2 | 2.3 | GO:0030135 | coated vesicle(GO:0030135) |
| 1.2 | 37.1 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
| 1.2 | 20.7 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 1.1 | 8.0 | GO:1990130 | Iml1 complex(GO:1990130) |
| 1.1 | 4.6 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 1.1 | 4.5 | GO:0000801 | central element(GO:0000801) |
| 1.1 | 68.5 | GO:0030133 | transport vesicle(GO:0030133) |
| 1.1 | 12.1 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 1.1 | 7.7 | GO:0030175 | filopodium(GO:0030175) |
| 1.1 | 58.5 | GO:0098793 | presynapse(GO:0098793) |
| 1.1 | 13.2 | GO:0016013 | syntrophin complex(GO:0016013) |
| 1.1 | 86.7 | GO:0005814 | centriole(GO:0005814) |
| 1.1 | 6.5 | GO:0005869 | dynactin complex(GO:0005869) |
| 1.1 | 1.1 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
| 1.1 | 132.8 | GO:0030427 | site of polarized growth(GO:0030427) |
| 1.1 | 3.2 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 1.1 | 12.8 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 1.1 | 2.1 | GO:1902636 | kinociliary basal body(GO:1902636) |
| 1.0 | 8.4 | GO:0072487 | MSL complex(GO:0072487) |
| 1.0 | 1.0 | GO:0030315 | T-tubule(GO:0030315) |
| 1.0 | 150.3 | GO:0005770 | late endosome(GO:0005770) |
| 1.0 | 1.0 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
| 1.0 | 16.0 | GO:0097546 | ciliary base(GO:0097546) |
| 1.0 | 29.6 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
| 1.0 | 4.8 | GO:0031985 | Golgi cisterna(GO:0031985) |
| 1.0 | 3.8 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.9 | 2.8 | GO:0070701 | mucus layer(GO:0070701) |
| 0.9 | 12.3 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.9 | 22.5 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
| 0.9 | 5.6 | GO:0031527 | filopodium membrane(GO:0031527) |
| 0.9 | 3.7 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
| 0.9 | 13.6 | GO:0030057 | desmosome(GO:0030057) |
| 0.9 | 68.7 | GO:0036064 | ciliary basal body(GO:0036064) |
| 0.9 | 3.6 | GO:1990879 | CST complex(GO:1990879) |
| 0.9 | 5.3 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
| 0.9 | 7.9 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
| 0.9 | 2.6 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.9 | 43.8 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
| 0.9 | 5.1 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
| 0.9 | 12.8 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.9 | 9.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.8 | 9.3 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.8 | 4.2 | GO:0032302 | MutSbeta complex(GO:0032302) |
| 0.8 | 1.7 | GO:1990393 | 3M complex(GO:1990393) |
| 0.8 | 5.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.8 | 14.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 0.8 | 22.4 | GO:0030673 | axolemma(GO:0030673) |
| 0.8 | 9.8 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.8 | 33.6 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
| 0.8 | 4.1 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
| 0.8 | 4.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 0.8 | 12.1 | GO:0097228 | sperm principal piece(GO:0097228) |
| 0.8 | 3.2 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.8 | 2.4 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
| 0.8 | 2.3 | GO:0031085 | BLOC-3 complex(GO:0031085) |
| 0.8 | 70.7 | GO:0055037 | recycling endosome(GO:0055037) |
| 0.8 | 6.8 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.7 | 11.1 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.7 | 1.4 | GO:0032426 | stereocilium tip(GO:0032426) |
| 0.7 | 5.6 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.7 | 4.9 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.7 | 5.5 | GO:0036038 | MKS complex(GO:0036038) |
| 0.7 | 2.7 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 0.7 | 2.0 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 0.7 | 5.4 | GO:0070187 | telosome(GO:0070187) |
| 0.7 | 4.0 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.7 | 15.2 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.7 | 3.3 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.6 | 2.6 | GO:0002177 | manchette(GO:0002177) |
| 0.6 | 1.9 | GO:0034657 | GID complex(GO:0034657) |
| 0.6 | 3.2 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 0.6 | 2.5 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.6 | 10.0 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.6 | 6.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.6 | 1.2 | GO:0030891 | VCB complex(GO:0030891) |
| 0.6 | 5.5 | GO:0016580 | Sin3 complex(GO:0016580) |
| 0.6 | 36.8 | GO:0031901 | early endosome membrane(GO:0031901) |
| 0.6 | 5.4 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.6 | 19.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.6 | 2.4 | GO:0045180 | basal cortex(GO:0045180) |
| 0.6 | 307.9 | GO:0000139 | Golgi membrane(GO:0000139) |
| 0.6 | 10.1 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.5 | 1.1 | GO:0051286 | cell tip(GO:0051286) |
| 0.5 | 52.6 | GO:0032587 | ruffle membrane(GO:0032587) |
| 0.5 | 6.7 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.5 | 70.4 | GO:0030424 | axon(GO:0030424) |
| 0.5 | 1.5 | GO:0097224 | sperm connecting piece(GO:0097224) |
| 0.5 | 1.0 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
| 0.5 | 5.3 | GO:0036126 | sperm flagellum(GO:0036126) |
| 0.5 | 1.0 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
| 0.5 | 44.0 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.5 | 0.5 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 0.5 | 1.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 0.5 | 5.9 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.4 | 46.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.4 | 15.5 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.4 | 2.2 | GO:1902560 | GMP reductase complex(GO:1902560) |
| 0.4 | 1.3 | GO:0031251 | PAN complex(GO:0031251) |
| 0.4 | 9.2 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
| 0.4 | 5.2 | GO:0043034 | costamere(GO:0043034) |
| 0.4 | 5.1 | GO:0000800 | lateral element(GO:0000800) |
| 0.4 | 2.0 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.4 | 4.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.4 | 41.8 | GO:0010008 | endosome membrane(GO:0010008) |
| 0.4 | 17.5 | GO:0044291 | cell-cell contact zone(GO:0044291) |
| 0.4 | 1.1 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
| 0.4 | 6.6 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 0.4 | 2.9 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
| 0.4 | 1.5 | GO:0060091 | kinocilium(GO:0060091) |
| 0.3 | 44.8 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
| 0.3 | 4.5 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.3 | 26.4 | GO:0005604 | basement membrane(GO:0005604) |
| 0.3 | 1.0 | GO:0034464 | BBSome(GO:0034464) |
| 0.3 | 1.3 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.3 | 14.5 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.3 | 5.9 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 0.3 | 3.4 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
| 0.3 | 55.4 | GO:0043025 | neuronal cell body(GO:0043025) |
| 0.3 | 3.5 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.3 | 5.1 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.3 | 5.5 | GO:0005776 | autophagosome(GO:0005776) |
| 0.3 | 0.3 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.2 | 9.5 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.2 | 5.6 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.2 | 1.2 | GO:0060171 | stereocilium membrane(GO:0060171) |
| 0.2 | 22.9 | GO:0031674 | I band(GO:0031674) |
| 0.2 | 0.4 | GO:0071546 | pi-body(GO:0071546) |
| 0.2 | 1.3 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.2 | 1.1 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
| 0.2 | 1.1 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.2 | 5.8 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.2 | 13.2 | GO:0030027 | lamellipodium(GO:0030027) |
| 0.2 | 1.9 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.2 | 0.4 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 0.2 | 14.1 | GO:0005875 | microtubule associated complex(GO:0005875) |
| 0.2 | 20.2 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
| 0.2 | 13.1 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.2 | 35.6 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
| 0.2 | 0.8 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
| 0.2 | 1.0 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.2 | 0.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 0.2 | 0.9 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 0.2 | 0.5 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 0.2 | 2.3 | GO:0030914 | STAGA complex(GO:0030914) |
| 0.2 | 1.2 | GO:0042599 | lamellar body(GO:0042599) |
| 0.1 | 28.4 | GO:0043235 | receptor complex(GO:0043235) |
| 0.1 | 0.4 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
| 0.1 | 0.6 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
| 0.1 | 0.7 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
| 0.1 | 2.2 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.1 | 57.7 | GO:0005794 | Golgi apparatus(GO:0005794) |
| 0.1 | 0.3 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.1 | 1.6 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
| 0.1 | 0.7 | GO:0051233 | spindle midzone(GO:0051233) |
| 0.1 | 1.5 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.1 | 352.8 | GO:0031224 | intrinsic component of membrane(GO:0031224) |
| 0.1 | 0.1 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
| 0.1 | 0.3 | GO:0043293 | apoptosome(GO:0043293) |
| 0.1 | 2.0 | GO:0005903 | brush border(GO:0005903) |
| 0.1 | 0.5 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
| 0.1 | 0.2 | GO:0071752 | dimeric IgA immunoglobulin complex(GO:0071750) secretory dimeric IgA immunoglobulin complex(GO:0071752) |
| 0.1 | 2.7 | GO:0090568 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) nuclear transcriptional repressor complex(GO:0090568) |
| 0.1 | 0.3 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.1 | 0.3 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.1 | 0.1 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
| 0.1 | 0.1 | GO:1990723 | cytoplasmic periphery of the nuclear pore complex(GO:1990723) |
| 0.1 | 0.7 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.1 | 0.2 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
| 0.0 | 0.2 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
| 0.0 | 0.0 | GO:0031082 | BLOC complex(GO:0031082) |
| 0.0 | 0.0 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 34.4 | 34.4 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 24.7 | 98.8 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 17.6 | 52.8 | GO:0031696 | alpha-2C adrenergic receptor binding(GO:0031696) |
| 16.3 | 65.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 13.3 | 53.2 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 13.3 | 39.9 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
| 13.0 | 51.8 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 12.5 | 50.1 | GO:0016211 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
| 12.4 | 49.6 | GO:0005163 | nerve growth factor receptor binding(GO:0005163) |
| 12.0 | 35.9 | GO:0031849 | olfactory receptor binding(GO:0031849) |
| 11.0 | 11.0 | GO:0052812 | phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) |
| 10.9 | 32.7 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
| 10.8 | 53.9 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
| 9.9 | 29.6 | GO:0052725 | inositol tetrakisphosphate 1-kinase activity(GO:0047325) inositol tetrakisphosphate kinase activity(GO:0051765) inositol-1,3,4-trisphosphate 6-kinase activity(GO:0052725) inositol-1,3,4-trisphosphate 5-kinase activity(GO:0052726) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) |
| 9.6 | 38.6 | GO:0047291 | neolactotetraosylceramide alpha-2,3-sialyltransferase activity(GO:0004513) lactosylceramide alpha-2,3-sialyltransferase activity(GO:0047291) |
| 9.3 | 46.3 | GO:1903135 | cupric ion binding(GO:1903135) |
| 8.9 | 35.7 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
| 8.9 | 115.3 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
| 8.6 | 25.9 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
| 8.6 | 94.4 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 8.6 | 34.2 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 8.1 | 48.3 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
| 7.9 | 47.4 | GO:0000285 | 1-phosphatidylinositol-3-phosphate 5-kinase activity(GO:0000285) |
| 7.8 | 62.3 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 7.4 | 66.7 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
| 7.3 | 22.0 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
| 7.3 | 14.5 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
| 7.2 | 86.0 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 7.1 | 127.0 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 7.0 | 7.0 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
| 7.0 | 90.4 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
| 6.6 | 26.5 | GO:0035939 | microsatellite binding(GO:0035939) |
| 6.3 | 25.3 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 6.3 | 43.9 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
| 5.9 | 17.7 | GO:0033142 | progesterone receptor binding(GO:0033142) |
| 5.8 | 23.1 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 5.6 | 22.5 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
| 5.6 | 16.9 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 5.5 | 21.9 | GO:0004773 | steryl-sulfatase activity(GO:0004773) |
| 5.4 | 65.2 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
| 5.4 | 16.2 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
| 5.4 | 26.9 | GO:0004803 | transposase activity(GO:0004803) |
| 5.4 | 32.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
| 5.4 | 171.3 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 5.3 | 48.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 5.3 | 21.1 | GO:0004077 | biotin-[acetyl-CoA-carboxylase] ligase activity(GO:0004077) biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity(GO:0004078) biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity(GO:0004079) biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity(GO:0004080) biotin-protein ligase activity(GO:0018271) |
| 5.3 | 15.8 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
| 5.1 | 20.5 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 5.1 | 20.5 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
| 5.0 | 176.0 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 4.9 | 78.3 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
| 4.6 | 27.5 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 4.5 | 54.0 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 4.5 | 18.0 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
| 4.4 | 56.9 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 4.3 | 34.2 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
| 4.3 | 17.1 | GO:0097001 | ceramide binding(GO:0097001) |
| 4.2 | 17.0 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
| 4.2 | 12.6 | GO:0036055 | protein-malonyllysine demalonylase activity(GO:0036054) protein-succinyllysine desuccinylase activity(GO:0036055) protein-glutaryllysine deglutarylase activity(GO:0061697) |
| 4.2 | 33.6 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 4.1 | 12.3 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
| 4.1 | 20.5 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
| 4.1 | 12.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 4.0 | 16.1 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 4.0 | 20.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 4.0 | 16.1 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
| 4.0 | 19.9 | GO:0052841 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
| 3.9 | 15.7 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
| 3.9 | 85.7 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
| 3.9 | 27.1 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
| 3.9 | 23.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 3.8 | 72.9 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 3.8 | 15.3 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
| 3.8 | 38.1 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
| 3.7 | 26.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 3.7 | 85.8 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 3.7 | 14.9 | GO:0004598 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
| 3.7 | 54.8 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 3.5 | 10.6 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 3.5 | 20.9 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 3.5 | 13.9 | GO:0001626 | nociceptin receptor activity(GO:0001626) |
| 3.5 | 117.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 3.4 | 10.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 3.4 | 10.1 | GO:0016429 | tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
| 3.3 | 10.0 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
| 3.3 | 19.9 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
| 3.3 | 16.4 | GO:0030375 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
| 3.2 | 19.4 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 3.2 | 45.3 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 3.2 | 19.4 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
| 3.2 | 16.1 | GO:1903136 | cuprous ion binding(GO:1903136) |
| 3.2 | 6.4 | GO:0038064 | collagen receptor activity(GO:0038064) |
| 3.2 | 19.2 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
| 3.2 | 19.0 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 3.2 | 28.5 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
| 3.1 | 245.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 3.1 | 59.6 | GO:0031005 | filamin binding(GO:0031005) |
| 3.1 | 15.7 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
| 3.1 | 37.5 | GO:0030911 | TPR domain binding(GO:0030911) |
| 3.1 | 15.5 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
| 3.1 | 43.2 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 3.1 | 27.7 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 3.1 | 12.3 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 3.0 | 9.1 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
| 3.0 | 21.3 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 3.0 | 15.1 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
| 3.0 | 20.8 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 2.9 | 14.7 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
| 2.9 | 8.7 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
| 2.9 | 14.3 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
| 2.8 | 39.9 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 2.8 | 5.7 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
| 2.8 | 117.6 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 2.8 | 5.6 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
| 2.8 | 33.2 | GO:0030552 | cAMP binding(GO:0030552) |
| 2.8 | 16.5 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 2.7 | 74.1 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 2.7 | 11.0 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
| 2.7 | 21.8 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 2.7 | 8.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 2.7 | 8.1 | GO:0033746 | histone demethylase activity (H3-R2 specific)(GO:0033746) histone demethylase activity (H4-R3 specific)(GO:0033749) |
| 2.7 | 5.4 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
| 2.7 | 10.6 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) |
| 2.6 | 92.5 | GO:0050780 | dopamine receptor binding(GO:0050780) |
| 2.6 | 7.9 | GO:0015218 | pyrimidine nucleotide transmembrane transporter activity(GO:0015218) |
| 2.6 | 89.2 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 2.6 | 10.4 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
| 2.6 | 2.6 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 2.6 | 15.5 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 2.6 | 7.7 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
| 2.6 | 15.4 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 2.6 | 2.6 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 2.6 | 10.2 | GO:0032567 | dGTPase activity(GO:0008832) triphosphoric monoester hydrolase activity(GO:0016793) guanyl deoxyribonucleotide binding(GO:0032560) dGTP binding(GO:0032567) |
| 2.6 | 12.8 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
| 2.5 | 40.8 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 2.5 | 7.6 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) Toll-like receptor 2 binding(GO:0035663) |
| 2.5 | 12.6 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
| 2.5 | 35.3 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 2.5 | 25.1 | GO:0004064 | arylesterase activity(GO:0004064) |
| 2.5 | 7.4 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 2.5 | 22.3 | GO:0016015 | morphogen activity(GO:0016015) |
| 2.5 | 54.4 | GO:0043274 | phospholipase binding(GO:0043274) |
| 2.5 | 44.5 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 2.5 | 4.9 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 2.5 | 12.3 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 2.5 | 150.2 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
| 2.5 | 17.2 | GO:0051425 | PTB domain binding(GO:0051425) |
| 2.4 | 9.8 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 2.4 | 36.7 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 2.4 | 7.3 | GO:0016497 | substance K receptor activity(GO:0016497) |
| 2.4 | 52.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 2.4 | 19.0 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 2.3 | 9.4 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
| 2.3 | 11.7 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
| 2.3 | 34.3 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
| 2.3 | 6.9 | GO:0086059 | voltage-gated calcium channel activity involved SA node cell action potential(GO:0086059) |
| 2.3 | 49.9 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 2.3 | 11.3 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 2.3 | 6.8 | GO:0036505 | prosaposin receptor activity(GO:0036505) |
| 2.3 | 29.4 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 2.2 | 8.9 | GO:0003867 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
| 2.2 | 6.6 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
| 2.2 | 11.0 | GO:0097016 | L27 domain binding(GO:0097016) |
| 2.2 | 58.1 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 2.1 | 47.1 | GO:0046961 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 2.1 | 6.4 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
| 2.1 | 6.3 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
| 2.1 | 8.4 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 2.1 | 48.5 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 2.1 | 4.2 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
| 2.1 | 8.4 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
| 2.1 | 14.5 | GO:0016403 | dimethylargininase activity(GO:0016403) |
| 2.1 | 12.3 | GO:1904315 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
| 2.1 | 16.4 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
| 2.0 | 10.2 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
| 2.0 | 12.1 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 2.0 | 14.0 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 2.0 | 19.8 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
| 2.0 | 55.1 | GO:0030506 | ankyrin binding(GO:0030506) |
| 2.0 | 39.3 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 2.0 | 7.8 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
| 2.0 | 23.5 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 1.9 | 9.7 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
| 1.9 | 7.7 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 1.9 | 36.7 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 1.9 | 7.7 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 1.9 | 40.4 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 1.9 | 5.7 | GO:0008431 | vitamin E binding(GO:0008431) |
| 1.9 | 24.9 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 1.9 | 1.9 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
| 1.9 | 83.7 | GO:0019894 | kinesin binding(GO:0019894) |
| 1.9 | 9.5 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 1.8 | 12.8 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 1.8 | 5.4 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
| 1.8 | 12.6 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 1.8 | 7.2 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
| 1.8 | 7.1 | GO:0070404 | NADH binding(GO:0070404) |
| 1.8 | 32.0 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 1.8 | 5.3 | GO:0032427 | GBD domain binding(GO:0032427) |
| 1.8 | 7.1 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
| 1.8 | 49.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 1.7 | 12.2 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
| 1.7 | 12.2 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 1.7 | 36.2 | GO:0005112 | Notch binding(GO:0005112) |
| 1.7 | 8.6 | GO:0004370 | glycerol kinase activity(GO:0004370) |
| 1.7 | 12.0 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
| 1.7 | 8.6 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
| 1.7 | 8.5 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
| 1.7 | 13.6 | GO:0015232 | heme transporter activity(GO:0015232) |
| 1.7 | 13.5 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 1.7 | 6.7 | GO:0004341 | gluconolactonase activity(GO:0004341) |
| 1.7 | 5.0 | GO:0019770 | IgG receptor activity(GO:0019770) |
| 1.7 | 5.0 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
| 1.7 | 8.3 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 1.7 | 36.6 | GO:0070840 | dynein complex binding(GO:0070840) |
| 1.7 | 26.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 1.7 | 1.7 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
| 1.6 | 69.3 | GO:0003785 | actin monomer binding(GO:0003785) |
| 1.6 | 4.9 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
| 1.6 | 9.8 | GO:0039552 | RIG-I binding(GO:0039552) |
| 1.6 | 16.2 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 1.6 | 29.0 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
| 1.6 | 11.3 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 1.6 | 28.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 1.6 | 9.6 | GO:0070728 | leucine binding(GO:0070728) |
| 1.6 | 14.4 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
| 1.6 | 6.4 | GO:0043492 | ATPase activity, coupled to movement of substances(GO:0043492) |
| 1.6 | 7.9 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 1.6 | 14.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 1.6 | 183.1 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 1.6 | 7.8 | GO:0071253 | connexin binding(GO:0071253) |
| 1.6 | 14.0 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 1.6 | 7.8 | GO:0000182 | rDNA binding(GO:0000182) |
| 1.5 | 9.3 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 1.5 | 77.2 | GO:0030507 | spectrin binding(GO:0030507) |
| 1.5 | 29.2 | GO:0005522 | profilin binding(GO:0005522) |
| 1.5 | 4.6 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 1.5 | 122.9 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
| 1.5 | 13.6 | GO:0034711 | inhibin binding(GO:0034711) |
| 1.5 | 9.0 | GO:0017040 | ceramidase activity(GO:0017040) |
| 1.5 | 10.5 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 1.5 | 7.5 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 1.5 | 31.4 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 1.5 | 6.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 1.5 | 29.6 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 1.5 | 14.8 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 1.5 | 5.9 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
| 1.4 | 4.3 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
| 1.4 | 2.9 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
| 1.4 | 10.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
| 1.4 | 7.1 | GO:0004122 | cystathionine beta-synthase activity(GO:0004122) |
| 1.4 | 28.5 | GO:0070403 | NAD+ binding(GO:0070403) |
| 1.4 | 44.1 | GO:0004890 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
| 1.4 | 4.2 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
| 1.4 | 15.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 1.4 | 19.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 1.4 | 220.7 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 1.4 | 4.1 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 1.4 | 67.6 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 1.4 | 6.9 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
| 1.4 | 13.7 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
| 1.4 | 2.7 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
| 1.4 | 2.7 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
| 1.4 | 9.5 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 1.4 | 4.1 | GO:0032093 | SAM domain binding(GO:0032093) |
| 1.3 | 7.9 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
| 1.3 | 18.4 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 1.3 | 9.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 1.3 | 6.5 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
| 1.3 | 7.8 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
| 1.3 | 6.5 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
| 1.3 | 18.2 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
| 1.3 | 7.8 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
| 1.3 | 37.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 1.3 | 26.7 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 1.3 | 7.6 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 1.3 | 5.1 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
| 1.3 | 10.0 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 1.3 | 23.8 | GO:0015248 | sterol transporter activity(GO:0015248) |
| 1.2 | 41.2 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 1.2 | 2.5 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
| 1.2 | 23.7 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 1.2 | 8.7 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
| 1.2 | 5.0 | GO:0050473 | arachidonate 15-lipoxygenase activity(GO:0050473) |
| 1.2 | 8.7 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 1.2 | 9.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 1.2 | 3.7 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
| 1.2 | 50.3 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 1.2 | 81.1 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 1.2 | 5.9 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
| 1.2 | 4.7 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 1.2 | 4.7 | GO:0016524 | latrotoxin receptor activity(GO:0016524) |
| 1.2 | 18.8 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 1.2 | 36.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 1.2 | 32.6 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 1.2 | 4.6 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 1.1 | 6.9 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 1.1 | 11.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 1.1 | 3.4 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
| 1.1 | 19.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
| 1.1 | 27.0 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 1.1 | 23.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
| 1.1 | 8.9 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
| 1.1 | 27.6 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 1.1 | 1.1 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) |
| 1.1 | 2.2 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 1.1 | 18.5 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 1.1 | 8.7 | GO:1990405 | protein antigen binding(GO:1990405) |
| 1.1 | 24.9 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 1.1 | 17.1 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 1.1 | 2.1 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
| 1.1 | 13.7 | GO:0005003 | ephrin receptor activity(GO:0005003) |
| 1.0 | 4.2 | GO:0033691 | sialic acid binding(GO:0033691) |
| 1.0 | 5.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
| 1.0 | 7.3 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
| 1.0 | 4.1 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 1.0 | 13.5 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 1.0 | 16.5 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 1.0 | 9.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
| 1.0 | 11.2 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 1.0 | 14.3 | GO:0009881 | photoreceptor activity(GO:0009881) |
| 1.0 | 5.0 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
| 1.0 | 6.0 | GO:0004882 | androgen receptor activity(GO:0004882) |
| 1.0 | 6.9 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
| 1.0 | 8.8 | GO:0043426 | MRF binding(GO:0043426) |
| 1.0 | 9.8 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 1.0 | 2.9 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
| 1.0 | 1.9 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
| 1.0 | 4.8 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
| 1.0 | 1.9 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
| 0.9 | 14.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 0.9 | 13.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.9 | 5.7 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.9 | 5.7 | GO:0000404 | heteroduplex DNA loop binding(GO:0000404) |
| 0.9 | 2.8 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
| 0.9 | 5.5 | GO:0008430 | selenium binding(GO:0008430) |
| 0.9 | 12.0 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.9 | 5.5 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 0.9 | 6.4 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 0.9 | 11.8 | GO:0019841 | retinol binding(GO:0019841) |
| 0.9 | 25.1 | GO:0017147 | Wnt-protein binding(GO:0017147) |
| 0.9 | 9.8 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 0.9 | 13.9 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
| 0.9 | 3.5 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.9 | 6.1 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 0.9 | 2.6 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
| 0.9 | 3.4 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 0.9 | 1.7 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.9 | 2.6 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
| 0.9 | 11.1 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
| 0.9 | 2.6 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
| 0.8 | 8.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.8 | 8.3 | GO:0016594 | glycine binding(GO:0016594) |
| 0.8 | 3.3 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
| 0.8 | 6.5 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
| 0.8 | 2.4 | GO:0070039 | rRNA (guanosine-2'-O-)-methyltransferase activity(GO:0070039) |
| 0.8 | 0.8 | GO:0047977 | hepoxilin-epoxide hydrolase activity(GO:0047977) |
| 0.8 | 4.8 | GO:0045295 | gamma-catenin binding(GO:0045295) |
| 0.8 | 3.2 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.8 | 5.6 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
| 0.8 | 3.1 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
| 0.8 | 3.9 | GO:0004471 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) oxaloacetate decarboxylase activity(GO:0008948) |
| 0.8 | 7.0 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.8 | 6.3 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
| 0.8 | 1.6 | GO:0010851 | cyclase regulator activity(GO:0010851) |
| 0.8 | 5.4 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
| 0.8 | 1.5 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
| 0.8 | 3.1 | GO:0045569 | TRAIL binding(GO:0045569) |
| 0.8 | 3.8 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
| 0.8 | 10.7 | GO:0001223 | transcription coactivator binding(GO:0001223) |
| 0.8 | 132.0 | GO:0008017 | microtubule binding(GO:0008017) |
| 0.8 | 9.1 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.8 | 9.8 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.8 | 3.8 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
| 0.7 | 2.2 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
| 0.7 | 6.7 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.7 | 2.2 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.7 | 2.2 | GO:0004336 | galactosylceramidase activity(GO:0004336) |
| 0.7 | 3.7 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 0.7 | 8.8 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.7 | 1.4 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
| 0.7 | 0.7 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.7 | 71.9 | GO:0017048 | Rho GTPase binding(GO:0017048) |
| 0.7 | 193.8 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.7 | 9.8 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.7 | 1.4 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
| 0.7 | 2.8 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 0.7 | 2.8 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
| 0.7 | 2.8 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
| 0.7 | 10.4 | GO:0004017 | adenylate kinase activity(GO:0004017) |
| 0.7 | 3.5 | GO:0008410 | CoA-transferase activity(GO:0008410) |
| 0.7 | 1.4 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
| 0.7 | 27.4 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
| 0.7 | 2.0 | GO:0001861 | complement component C4b receptor activity(GO:0001861) complement component C3b receptor activity(GO:0004877) |
| 0.7 | 12.1 | GO:0015145 | monosaccharide transmembrane transporter activity(GO:0015145) |
| 0.7 | 2.7 | GO:0038132 | neuregulin binding(GO:0038132) |
| 0.7 | 4.7 | GO:0045159 | myosin II binding(GO:0045159) |
| 0.7 | 2.7 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
| 0.7 | 24.5 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
| 0.6 | 1.3 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.6 | 7.0 | GO:0043295 | glutathione binding(GO:0043295) |
| 0.6 | 1.9 | GO:0004584 | dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity(GO:0004584) |
| 0.6 | 2.5 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.6 | 15.3 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.6 | 6.7 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
| 0.6 | 2.4 | GO:0004925 | prolactin receptor activity(GO:0004925) |
| 0.6 | 4.9 | GO:0048406 | neurotrophin binding(GO:0043121) nerve growth factor binding(GO:0048406) |
| 0.6 | 15.8 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.6 | 0.6 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
| 0.6 | 5.4 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 0.6 | 1.8 | GO:0060001 | minus-end directed microfilament motor activity(GO:0060001) |
| 0.6 | 1.8 | GO:0047708 | biotinidase activity(GO:0047708) |
| 0.6 | 2.4 | GO:0052590 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
| 0.6 | 10.0 | GO:0008198 | ferrous iron binding(GO:0008198) |
| 0.6 | 11.8 | GO:0043394 | proteoglycan binding(GO:0043394) |
| 0.6 | 1.8 | GO:0030350 | iron-responsive element binding(GO:0030350) |
| 0.6 | 57.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.6 | 4.1 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
| 0.6 | 2.9 | GO:0004522 | ribonuclease A activity(GO:0004522) |
| 0.6 | 1.7 | GO:0035473 | lipase binding(GO:0035473) |
| 0.6 | 4.0 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.6 | 1.2 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
| 0.6 | 11.4 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.6 | 66.1 | GO:0005516 | calmodulin binding(GO:0005516) |
| 0.6 | 1.7 | GO:0032090 | Pyrin domain binding(GO:0032090) |
| 0.6 | 4.5 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
| 0.6 | 7.8 | GO:0051018 | protein kinase A binding(GO:0051018) |
| 0.6 | 1.7 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 0.6 | 10.5 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
| 0.6 | 4.4 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
| 0.5 | 6.0 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
| 0.5 | 11.0 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.5 | 19.7 | GO:0030276 | clathrin binding(GO:0030276) |
| 0.5 | 9.8 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.5 | 62.3 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.5 | 13.4 | GO:0017022 | myosin binding(GO:0017022) |
| 0.5 | 3.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.5 | 4.8 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
| 0.5 | 20.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.5 | 4.8 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.5 | 6.3 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) BMP receptor binding(GO:0070700) |
| 0.5 | 10.9 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.5 | 1.6 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.5 | 3.6 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 0.5 | 10.3 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
| 0.5 | 1.0 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.5 | 4.1 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
| 0.5 | 1.5 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
| 0.5 | 3.0 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
| 0.5 | 1.5 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.5 | 12.4 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
| 0.5 | 16.8 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
| 0.5 | 0.5 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
| 0.5 | 3.9 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
| 0.5 | 2.9 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.5 | 11.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.5 | 5.7 | GO:0003774 | motor activity(GO:0003774) |
| 0.5 | 2.8 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
| 0.5 | 8.5 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
| 0.5 | 2.8 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
| 0.5 | 4.2 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
| 0.5 | 1.9 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 0.5 | 0.9 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) |
| 0.5 | 0.5 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 0.5 | 0.9 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
| 0.5 | 5.0 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
| 0.4 | 1.3 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 0.4 | 2.2 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
| 0.4 | 11.5 | GO:0005158 | insulin receptor binding(GO:0005158) |
| 0.4 | 10.6 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.4 | 0.4 | GO:0031705 | bombesin receptor binding(GO:0031705) |
| 0.4 | 2.2 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 0.4 | 45.3 | GO:0044325 | ion channel binding(GO:0044325) |
| 0.4 | 1.3 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
| 0.4 | 1.3 | GO:0070119 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) ciliary neurotrophic factor binding(GO:0070119) |
| 0.4 | 3.5 | GO:0019863 | IgE binding(GO:0019863) |
| 0.4 | 0.8 | GO:0098518 | polynucleotide 5'-phosphatase activity(GO:0004651) polynucleotide phosphatase activity(GO:0098518) |
| 0.4 | 1.3 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
| 0.4 | 1.2 | GO:0015616 | DNA translocase activity(GO:0015616) |
| 0.4 | 3.3 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
| 0.4 | 2.0 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
| 0.4 | 2.8 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.4 | 6.3 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.4 | 2.0 | GO:0048039 | ubiquinone binding(GO:0048039) |
| 0.4 | 5.9 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
| 0.4 | 25.1 | GO:0035064 | methylated histone binding(GO:0035064) |
| 0.4 | 5.1 | GO:0008327 | methyl-CpG binding(GO:0008327) |
| 0.4 | 0.4 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.4 | 8.6 | GO:0099589 | serotonin receptor activity(GO:0099589) |
| 0.4 | 2.3 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 0.4 | 5.0 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.4 | 5.4 | GO:0015250 | water channel activity(GO:0015250) |
| 0.4 | 2.7 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
| 0.4 | 1.5 | GO:0032408 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
| 0.4 | 1.1 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
| 0.4 | 3.7 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.4 | 1.4 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.4 | 11.4 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
| 0.3 | 1.0 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
| 0.3 | 0.7 | GO:0031685 | adenosine receptor binding(GO:0031685) |
| 0.3 | 0.3 | GO:0001855 | complement component C4b binding(GO:0001855) |
| 0.3 | 3.5 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.3 | 5.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
| 0.3 | 0.3 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) |
| 0.3 | 3.0 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.3 | 2.3 | GO:0042923 | neuropeptide binding(GO:0042923) |
| 0.3 | 1.0 | GO:0015489 | polyamine transmembrane transporter activity(GO:0015203) putrescine transmembrane transporter activity(GO:0015489) |
| 0.3 | 1.0 | GO:0052815 | medium-chain acyl-CoA hydrolase activity(GO:0052815) long-chain acyl-CoA hydrolase activity(GO:0052816) |
| 0.3 | 3.2 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
| 0.3 | 0.6 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
| 0.3 | 0.9 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.3 | 0.9 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
| 0.3 | 1.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.3 | 0.6 | GO:0043199 | sulfate binding(GO:0043199) |
| 0.3 | 7.4 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
| 0.3 | 0.9 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
| 0.3 | 0.6 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
| 0.3 | 26.6 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
| 0.3 | 1.4 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
| 0.3 | 0.3 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
| 0.3 | 0.8 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
| 0.3 | 0.8 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
| 0.3 | 2.4 | GO:0008066 | glutamate receptor activity(GO:0008066) |
| 0.3 | 0.5 | GO:0042008 | interleukin-18 receptor activity(GO:0042008) |
| 0.3 | 10.1 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
| 0.3 | 2.3 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 0.3 | 5.1 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.3 | 0.8 | GO:0052794 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
| 0.2 | 0.5 | GO:0097259 | leukotriene-B4 20-monooxygenase activity(GO:0050051) tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
| 0.2 | 4.4 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.2 | 0.7 | GO:0004912 | interleukin-3 receptor activity(GO:0004912) |
| 0.2 | 0.5 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
| 0.2 | 4.1 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
| 0.2 | 0.5 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
| 0.2 | 1.2 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
| 0.2 | 1.2 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 0.2 | 0.9 | GO:0042015 | interleukin-20 binding(GO:0042015) |
| 0.2 | 6.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.2 | 1.4 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
| 0.2 | 0.7 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
| 0.2 | 0.9 | GO:0046592 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
| 0.2 | 2.9 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
| 0.2 | 0.7 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
| 0.2 | 2.9 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
| 0.2 | 0.2 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
| 0.2 | 1.1 | GO:0070061 | fructose binding(GO:0070061) |
| 0.2 | 0.6 | GO:0004750 | ribulose-phosphate 3-epimerase activity(GO:0004750) |
| 0.2 | 0.2 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
| 0.2 | 0.8 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.2 | 21.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.2 | 1.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.2 | 1.2 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
| 0.2 | 3.7 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.2 | 0.6 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.2 | 0.8 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 0.2 | 117.0 | GO:0005509 | calcium ion binding(GO:0005509) |
| 0.2 | 0.6 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
| 0.2 | 1.3 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
| 0.2 | 0.2 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
| 0.2 | 1.1 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
| 0.2 | 0.9 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
| 0.2 | 0.9 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
| 0.2 | 0.7 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 0.2 | 0.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
| 0.2 | 1.4 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.2 | 0.6 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
| 0.2 | 0.6 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
| 0.2 | 0.3 | GO:0030172 | troponin C binding(GO:0030172) |
| 0.2 | 0.6 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
| 0.2 | 1.5 | GO:0008061 | chitinase activity(GO:0004568) chitin binding(GO:0008061) |
| 0.1 | 0.7 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.1 | 0.4 | GO:0005497 | androgen binding(GO:0005497) |
| 0.1 | 0.9 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
| 0.1 | 0.6 | GO:0051748 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
| 0.1 | 0.4 | GO:0005055 | laminin receptor activity(GO:0005055) |
| 0.1 | 0.7 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
| 0.1 | 1.9 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
| 0.1 | 4.8 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.1 | 0.1 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
| 0.1 | 0.4 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
| 0.1 | 6.3 | GO:0008009 | chemokine activity(GO:0008009) |
| 0.1 | 0.7 | GO:0001847 | opsonin receptor activity(GO:0001847) |
| 0.1 | 0.4 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 0.1 | 0.9 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.1 | 0.9 | GO:1990239 | steroid hormone binding(GO:1990239) |
| 0.1 | 1.0 | GO:0048156 | tau protein binding(GO:0048156) |
| 0.1 | 0.2 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
| 0.1 | 0.4 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
| 0.1 | 0.4 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
| 0.1 | 0.5 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
| 0.1 | 37.8 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
| 0.1 | 0.4 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
| 0.1 | 1.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.1 | 0.3 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.1 | 0.3 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 0.1 | 0.5 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.1 | 1.1 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.1 | 0.2 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.1 | 9.7 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
| 0.1 | 0.2 | GO:0046997 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
| 0.1 | 0.3 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
| 0.1 | 0.3 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.1 | 0.3 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
| 0.0 | 0.2 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
| 0.0 | 0.6 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 0.0 | 0.0 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
| 0.0 | 0.1 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
| 0.0 | 0.0 | GO:0003909 | DNA ligase activity(GO:0003909) |
| 0.0 | 0.3 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
| 0.0 | 0.5 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 0.0 | 0.1 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
| 0.0 | 1.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.0 | 0.3 | GO:0019864 | IgG binding(GO:0019864) |
| 0.0 | 0.5 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.0 | 0.2 | GO:0070330 | aromatase activity(GO:0070330) |
| 0.0 | 0.4 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
| 0.0 | 0.1 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
| 0.0 | 0.2 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
| 0.0 | 0.1 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.0 | 0.1 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
| 0.0 | 0.5 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.0 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.4 | 182.9 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 3.5 | 97.7 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 3.1 | 162.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 2.4 | 134.1 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 2.3 | 11.5 | PID S1P S1P3 PATHWAY | S1P3 pathway |
| 2.2 | 129.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 2.2 | 52.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 2.2 | 12.9 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 2.1 | 139.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
| 2.1 | 29.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 1.9 | 101.0 | PID ARF6 PATHWAY | Arf6 signaling events |
| 1.9 | 48.2 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
| 1.8 | 110.3 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 1.7 | 78.9 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
| 1.7 | 34.7 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 1.6 | 74.9 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 1.6 | 135.0 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 1.6 | 57.6 | PID REELIN PATHWAY | Reelin signaling pathway |
| 1.5 | 6.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
| 1.5 | 57.6 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 1.4 | 8.6 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 1.4 | 12.7 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
| 1.4 | 2.7 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 1.3 | 9.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 1.2 | 44.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 1.2 | 47.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 1.2 | 13.3 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
| 1.1 | 34.7 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 1.1 | 4.5 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 1.1 | 49.0 | PID LKB1 PATHWAY | LKB1 signaling events |
| 1.1 | 12.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 1.0 | 21.5 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
| 1.0 | 41.6 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 1.0 | 38.2 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.9 | 4.6 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.9 | 18.0 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.9 | 40.0 | PID FGF PATHWAY | FGF signaling pathway |
| 0.8 | 12.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.8 | 53.7 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.8 | 3.2 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
| 0.8 | 10.8 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.8 | 2.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.8 | 30.6 | PID SHP2 PATHWAY | SHP2 signaling |
| 0.8 | 14.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.7 | 15.5 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.7 | 12.8 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.7 | 18.4 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.7 | 14.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.7 | 9.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.6 | 18.0 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.6 | 3.2 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
| 0.6 | 17.9 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.6 | 6.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.6 | 42.6 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
| 0.6 | 7.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.6 | 3.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.6 | 17.8 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.6 | 13.6 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.6 | 16.9 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.6 | 2.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.5 | 3.2 | ST GAQ PATHWAY | G alpha q Pathway |
| 0.5 | 20.1 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
| 0.5 | 3.6 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
| 0.5 | 1.0 | ST STAT3 PATHWAY | STAT3 Pathway |
| 0.5 | 12.2 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.5 | 1.4 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.5 | 3.6 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
| 0.4 | 10.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.4 | 15.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.4 | 3.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.4 | 100.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.4 | 6.9 | PID ENDOTHELIN PATHWAY | Endothelins |
| 0.4 | 4.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
| 0.4 | 8.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.4 | 5.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.3 | 17.7 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 0.3 | 1.3 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.3 | 3.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.3 | 1.4 | NABA MATRISOME | Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins |
| 0.3 | 15.4 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.2 | 1.2 | ST GA13 PATHWAY | G alpha 13 Pathway |
| 0.2 | 14.5 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.2 | 44.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.2 | 2.8 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 0.2 | 3.0 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.2 | 6.1 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.2 | 1.3 | PID IL3 PATHWAY | IL3-mediated signaling events |
| 0.2 | 50.8 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.2 | 2.9 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.2 | 0.8 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.1 | 2.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.1 | 1.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.1 | 2.2 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
| 0.1 | 11.6 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.1 | 0.5 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.1 | 0.6 | PID INSULIN PATHWAY | Insulin Pathway |
| 0.1 | 1.8 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.1 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.1 | 1.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.1 | 3.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.1 | 0.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.1 | 1.0 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.1 | 0.6 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 0.1 | 1.6 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.0 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
| 0.0 | 6.1 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 7.3 | 168.4 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 5.6 | 186.3 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 4.8 | 133.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 4.7 | 4.7 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
| 4.1 | 206.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 4.0 | 209.4 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 3.9 | 169.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 3.9 | 77.7 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 3.9 | 89.0 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 3.9 | 27.1 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
| 3.7 | 3.7 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
| 3.7 | 73.8 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
| 3.7 | 198.9 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 3.5 | 24.7 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 3.3 | 127.7 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
| 3.2 | 16.0 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 3.1 | 139.1 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 3.0 | 24.2 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
| 3.0 | 9.0 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
| 2.8 | 51.2 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 2.7 | 35.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
| 2.6 | 67.9 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
| 2.6 | 12.9 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
| 2.5 | 61.5 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 2.4 | 40.2 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
| 2.3 | 33.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 2.2 | 35.9 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 2.2 | 4.5 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
| 2.2 | 47.9 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
| 2.1 | 31.8 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 2.0 | 2.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 1.9 | 55.7 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 1.9 | 48.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 1.8 | 41.8 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
| 1.8 | 45.9 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
| 1.7 | 43.0 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 1.7 | 37.8 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
| 1.7 | 57.2 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 1.6 | 54.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 1.6 | 25.3 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 1.6 | 10.9 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 1.5 | 72.8 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
| 1.5 | 28.8 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
| 1.4 | 33.2 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 1.4 | 82.8 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 1.4 | 4.2 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
| 1.4 | 15.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 1.3 | 6.6 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
| 1.3 | 12.9 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
| 1.3 | 26.9 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 1.3 | 20.1 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 1.3 | 5.0 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
| 1.2 | 23.7 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
| 1.2 | 13.5 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 1.2 | 152.4 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
| 1.2 | 8.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 1.1 | 47.1 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
| 1.1 | 34.5 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 1.1 | 21.8 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 1.1 | 18.8 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 1.1 | 59.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 1.1 | 28.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 1.1 | 11.9 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 1.1 | 12.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 1.1 | 1.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 1.1 | 35.2 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
| 1.0 | 5.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
| 1.0 | 20.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 1.0 | 5.0 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 1.0 | 189.5 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
| 1.0 | 3.9 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
| 1.0 | 17.5 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
| 1.0 | 25.0 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.9 | 129.9 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.9 | 2.8 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
| 0.9 | 8.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.9 | 11.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.8 | 10.2 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
| 0.8 | 13.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.8 | 20.9 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.8 | 11.6 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.8 | 61.8 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.7 | 82.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.7 | 16.1 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
| 0.7 | 24.7 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.7 | 13.0 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.7 | 51.9 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
| 0.7 | 5.4 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.6 | 23.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.6 | 15.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.6 | 6.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
| 0.6 | 1.8 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
| 0.6 | 16.3 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
| 0.5 | 9.8 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.5 | 3.7 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.5 | 16.2 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
| 0.5 | 8.3 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 0.5 | 41.8 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
| 0.5 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
| 0.5 | 1.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.5 | 11.5 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
| 0.5 | 2.5 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 0.5 | 8.5 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
| 0.4 | 1.7 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
| 0.4 | 22.8 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.4 | 5.4 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.4 | 2.7 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
| 0.4 | 15.8 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
| 0.4 | 1.5 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
| 0.4 | 6.0 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.3 | 3.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.3 | 1.6 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.3 | 6.2 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.3 | 2.3 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 0.3 | 10.2 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.3 | 5.0 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
| 0.3 | 6.3 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.2 | 2.2 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
| 0.2 | 0.2 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
| 0.2 | 8.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.2 | 2.0 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
| 0.2 | 0.8 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.2 | 2.2 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.2 | 7.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.2 | 1.5 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
| 0.1 | 1.5 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
| 0.1 | 2.7 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.1 | 0.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 0.1 | 0.9 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.1 | 1.9 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 0.1 | 0.7 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.1 | 1.0 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.1 | 0.8 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.1 | 0.6 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
| 0.1 | 4.2 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
| 0.1 | 0.4 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
| 0.1 | 0.9 | REACTOME PI3K EVENTS IN ERBB2 SIGNALING | Genes involved in PI3K events in ERBB2 signaling |
| 0.1 | 0.5 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.0 | 0.6 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
| 0.0 | 0.4 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
| 0.0 | 0.3 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |